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Abstract: The development of biotechnological protocols based on cationic surfactants is a modern 
trend focusing on the fabrication of antimicrobial and bioimaging agents, supramolecular catalysts, 
stabilizers of nanoparticles, and especially drug and gene nanocarriers. The main emphasis given 
to the design of novel ecologically friendly and biocompatible cationic surfactants makes it possible 
to avoid the drawbacks of nanoformulations preventing their entry to clinical trials. To solve the 
problem of toxicity various ways are proposed, including the use of mixed composition with 
nontoxic nonionic surfactants and/or hydrotropic agents, design of amphiphilic compounds bearing 
natural or cleavable fragments. Essential advantages of cationic surfactants are the structural 
diversity of their head groups allowing of chemical modification and introduction of desirable 
moiety to answer the green chemistry criteria. The latter can be exemplified by the design of novel 
families of ecological friendly cleavable surfactants, with improved biodegradability, amphiphiles 
with natural fragments, and geminis with low aggregation threshold. Importantly, the development 
of amphiphilic nanocarriers for drug delivery allows understanding the correlation between the 
chemical structure of surfactants, their aggregation behavior, and their functional activity. This 
review focuses on several aspects related to the synthesis of innovative cationic surfactants and their 
broad biological applications including antimicrobial activity, solubilization of hydrophobic drugs, 
complexation with DNA, and catalytic effect toward important biochemical reaction. 
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1. Introduction 
Cationic surfactants are amphiphilic compounds, which can dissociate in water with the 
formation of surface-active cations. These molecules have the capacity of self-assembling [1], being 
widely used in biotechnology [2,3]. It can be expected that cationic charge of amphiphilic molecules 
should play an important role in biotechnological applications, determining the huge potential of 
cationic amphiphilic agents as drug carriers in pharmacy and biomedicine. Among them, those with 
a quaternary ammonium (QA) head group are of high relevance from the practical viewpoint with 
wide biotechnological applications [4]. 
Occurrence of positively charged fragments in amphiphilic scaffold is responsible for their 
attractiveness in nanotechnological applications as antimicrobial and bioimaging agents [5,6], 
corrosion inhibitors [7], supramolecular catalysts [8], stabilizers of nanoparticles and nanocarriers 
[9,10], and, especially as, drug and gene nanocarriers [11]. Cationic head groups of surfactants 
provide their high affinity toward biopolyanions, such as DNA [12,13], cell membranes, and 
intracellular organelles, such as mitochondrion, thereby initiating the development of perspective 
field of therapy, the so-called mitochondrion medicine [14,15]. Essential advantages of cationic 
surfactants are the diversity of their head groups allowing chemical modification and introduction 
of desirable moiety to answer the biotechnological criteria. The latter can be exemplified by the design 
of novel families of ecological friendly cleavable surfactants [16], with improved biodegradability, 
amphiphiles with natural fragments [17], and geminis with low aggregation threshold, including 
those bearing hydroxyl-groups capable of hydrogen bonding [18], among others. 
Despite the fact that general positive trend occurs in the development of biotechnological 
protocols based on cationic surfactants including their use in the treatment of virulent diseases, the 
toxicity of cationic amphiphiles remains the main problem preventing their wide practical 
applications. Starting with the first and second generations of cationic charged liposomes [19], 
preclinical and clinical results testify the promising cationic liposomal therapy in the future [20]. In 
2005, Medigene has developed paclitaxel encapsulated in positively charged lipid-based complexes 
for the potential treatment of cancer [21]. More recently, MediGene obtained positive results with 
EndoTAGTM-1 in a controlled phase II clinical trial in pancreatic cancer and triple receptor-negative 
breast cancer [22]. To date, few cationic agents and formulations are known to have application in 
ophthalmic practice [23–25]. However, the high effectiveness and potential applications of cationic 
surfactants continue to attract much attention of researchers, with main emphasis given to the design 
of novel ecologically friendly and biocompatible cationic surfactants. To solve the problem of toxicity, 
different ways are proposed, including the use of mixed composition with nontoxic nonionic 
surfactants and/or hydrotropic agents [26] in the design of amphiphilic compounds bearing natural 
fragments, some of which will be discussed herein. 
A series of works focusing on the application of cationic surfactants in drug delivery have been 
recently reviewed [27], with emphasis given to their use for gene therapy [28–31], as a template for 
the synthesis of mesoporous materials [32], and also to their biocidal action against bacteria and fungi 
[33,34]. In this review, the fundamental approach based on structure-activity correlations between 
the chemical structure and self-assembly properties of amphiphilic compounds, in combination with 
their impact on functional activity of supramolecular systems, is taken as a basis for the analysis and 
recommendations made. The structure-activity correlation will be exemplified by the systematic 
study of series of mono-, di-, and tetra-cationic derivatives of 1,4-diazobicyclo[2.2.2]octane (DABCO) 
of different hydrophobicity and some amphiphilic molecules with natural fragments. 
2. Structural Diversity of Biocompatible and Ecologically Friendly Cationic Surfactants  
One of the promising approaches in the design of building blocks for biomedical applications, 
which include formulations for drug delivery, is the creation of new multifunctional environmentally 
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friendly, cleavable, green, and less toxic cationic surfactant systems answering the biotechnological 
criteria and improving biocompatibility, solubility, bioavailability, and biodegradability of 
therapeutics [35–37]. The promising strategy in this way is the design of cationic systems containing 
several covalently bound hydrophobic, hydrophilic groups, and various spacers to decrease 
surfactant concentration thresholds. In this review, we have therefore started from the so-called 
gemini surfactants demonstrating low aggregation threshold and morphological lability [38,39]. To 
promote surfactant biodegradation and ecological safety, strategies for preparation of surfactant with 
hydrolysable ester bonds and cleavable amide links were employed. The new class of biocompatible 
surfactants with polar head groups containing natural moiety such as sugar-, peptide-, and 
pyrimidine-bearing moieties are promising drug and gene carriers for intracellular delivery [40]. 
Importantly, they provide a widened spectrum of intermolecular interaction (hydrogen bonding, 
electrostatic, and van der Waals), stacking and complementary interactions upon self-assembly, and 
binding the drug, thereby combining high efficacy with lower toxicity [41,42].  
2.1. Gemini Surfactants 
In recent years, particular attention is focused on gemini surfactants due to their advanced 
structure-activity correlation, superior aggregation capacity, and versatile morphological behavior 
[4,43]. Unlike conventional single head surfactants, gemini analogs consist of two equal head groups 
bearing two tails bridged with a spacer. Typically, the ammonium is substituted by two methyl 
groups or short alkyl chain group and a long aliphatic alkyl chain, which contributes with its 
lipophilicity to the overall amphiphilic character of the molecule. The length and nature (flexibility 
and hydrophilicity) of the spacer may serve as a tool for the tuning of their size, shape, and 
morphology, including sphere-to-rod or micelle-to-vesicle structural transitions [44,45]. Alkyl chains 
of various lengths (C2 to C10) are most frequently used, being the properties of the gemini surfactant 
in question influenced by the fact if odd or even number of ethylene groups are used [46].  
The simplest QA gemini surfactants (1a) are based on two molecules of the prototype quaternary 
ammonium surfactant (QAS), cetyl trimethyl ammonium bromide (CTAB), or dodecyl trimethyl 
ammonium bromide (DTAB), linked by an alkyl spacer at the ammonium group. Examples of such 
structures are presented in Figure 1. The structure is usually annotated as m-s-m, where m and s 
represent the number of carbon atoms in alkyl chains and in polymethylene spacers, respectively. 
The quaternary ammonium group can also be contained in an imidazole heterocycle (1b). In this case, 
a long alkyl chain providing lipophilicity is linked to 3’ nitrogen in the imidazole ring, and a spacer 
links 1’ quaternary ammoniums.  
Alternatively, cationic QA gemini surfactants may also contain a natural moiety [47–49]). 
Examples are: (i) glucose moieties containing gemini surfactant (1c), where the spacer links the 
monomers at hydroxyl group of glucose moiety [49], as shown in Figure 1 and (ii) serine-based 
cationic gemini surfactant (1d), where the spacer links two serine nitrogen atoms, quaternarized by 
substitution with a long alkyl chain [48], Figure 1. 
Due to their enhanced hydrophobicity, gemini surfactants demonstrate much lower critical 
micelle concentration (CMC), as compared to conventional surfactants. Conductomery, tensiometry, 
potentiometry, and other data indicate that a decrease in CMC by about two orders of magnitude 
occurs on transiting from monocationic to gemini surfactants with the same alkyl tail [50]. In the case 
of dicationic surfactants with hydroxyethyl fragment in the head group, an additional five-fold 
decrease in the CMC value is observed [51]. Another important feature of gemini surfactants is their 
enhanced solubilization capacity, exemplified by solubility of p-nitrophenyl esters of carbonic acid in 
mono and dicationic surfactant solutions, as compared to water [52]. 
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Figure 1. Examples of cationic quaternary ammonium surfactants, 1a: R = CnHn+1, s = 4; 1b: R = CnHn+1, 
n = 2,4; 1c: R = C12H25, C16H37, C18H37, n = 3; 1d: n = 10; 1f: R = C10H21, X− = Br−; 1g: n = 10, 12, 14; and 1h: 
n = 6, 9, 12.  
The introduction of a labile group, typically an ester group, results in production of an easily 
cleavable molecule, which degradation would begin exactly at the ester group. The ester group can 
be introduced between quaternary ammonium head and alkyl tail (1e) (Figure 1) [53], or in the spacer 
[54]. The former type falls in the group of esters quat surfactants, which are cleaved at the ester groups 
forming much less active products, offering, thus, a biodegradable and environmentally friendly 
class of surfactants. The latter group degrades into two QA molecules differing in hydroxyethyl- or 
hydroxymethyl-chain, produced by the cleavage of the asymmetric spacer. The resulting products 
maintain surface activity, but this is greatly inferior compared to the original gemini [54]. 
2.2. Ionic Liquids  
Other types of ecologically friendly amphiphiles that have gained much interest are the ionic 
liquids (IL), especially those bearing methylimidazolium (mim) cation. Dicationic imidazolium 
surfactants were reported to be used as supramolecular models of anionic abiotic receptors and 
exhibit high binding activity to anionic drugs exemplified by valproate [55].  
Lauryl isoquinolinium bromide, studied by Zhang et al. [56], was compared with homologs of 
different hydrophobicities and with typical surfactant lauryl pyridinium bromide. The CMC value 
evaluated was treated in term of π-π stacking effect contributed by aromatic rings. Rheological 
behavior of IL C14mimBr in aqueous solution has been evaluated in the presence of sodium salicylate 
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[57]. Maximal viscoelastic properties are found to correspond to the 1:0.6 surfactant/salt molar ratio 
and to be contributed by ion-pairing between them. Novel class of IL with short alkyl tails and long 
chain counter-ions that form catanionic surfactants have been designed. Three ionic liquids based on 
the imidazolium cation with rather short alky tails (n ≤ 8) and ibuprofenate as counterion have been 
synthesized [58]. The morphology and composition of aggregates are strongly controlled by alkyl 
chain length associated with imidazolium cation. Under the dilution regime, the micelle-to-vesicle 
transition can occur. In an analogous manner, salt-free catanionic IL based on alkylated mim as 
cationic head (n varied from 6 to 10) and alkyl sulfates as counterions were prepared [59]. 
Amphiphilic character of IL synthesized can be tailored by the hydrophobicity of both cationic group 
and counterion, with CMC markedly decreasing with an increase in alkyl chain length.  
Hydrophobized imidazolium salts studied are capable of self-assembling with the formation of 
vesicles without any additives or impulses [60]. This has been attributed to the specific packing 
parameter of the molecules. Mester et al. [61] addressed the toxicity of the mim-based IL with the role 
of counterion emphasized and reported that the chaotropicity of the anion is shown to be a key factor 
controlling the toxicity of IL studied. The genotoxicity of nanoparticles decorated with the 
imidazolium salts was lower compared with those covered with other cationic surfactants [62,63]. A 
weak point for IL is the fact they pose several risks to human health and environment; thus, the 
positive impact of IL should be evaluated with due caution. 
2.3. Cationic QA Surfactants Containing a Natural Moiety  
In an effort to obtain quaternary ammonium compounds (QASs) that would be less toxic than 
existing cationic surfactants, novel quaternary ammonium compounds (QACs) that contain a natural 
moiety have been synthetized by various research groups. The natural moieties include 
nucleotides/nucleosides (nucleolipids), amino acids (lipoaminoacids), peptides, and diterpenoids. By 
making use of naturally occurring materials, it is believed that the resulting novel cationic surfactants 
provide better biocompatibility and limited toxicity and improve the environmental safety profile. 
Many of these compounds contain a cleavable group in order to provide a compound that 
decomposes easily to less active or inactive molecules. These cleavable compounds fulfil the 
prerequisites of biodegradable, environmentally friendly surfactants. 
2.3.1. Pyrimidinophanes: Macrocycles with Nucleotide/Nucleoside Moiety 
Special class of hybrid amphiphiles involves the so-called nucleolipids that are composed of 
hydrophobic tails covalently bound to nucleotide or nucleoside moieties. A wide series of novel 
macocyclic, dicationic amphiphiles bearing pyrimidinic fragment (1f) (Figure 1), in particular, uracil, 
have been studied. An excellent review of pyrimidinophanes structure, synthesis, and application by 
V.E. Semenov is recommended for further, detailed reading [64]. 
Acyclic and macrocyclic pyrimidinophane analogs with varied size of macrocycle, alkyl chain 
length, and counter-ion nature were compared. Kharmalov et al. [65] studied aggregation behavior 
of a pyrimidinocyclophane with an uracil moiety. This pyrimidinocyclophane has cationic character 
at pH = 1 and is insoluble in water at pH < 4 were it forms cationic aggregates. An unusual structural 
transition has been revealed from large aggregates to lower micelle-like assemblies with an increase 
in amphiphile concentration, reversibly soluble upon increase of environment pH. The studied 
pyrimidinocyclophane forms, in excess with Triton X-100, stable, normal micelle aggregates in 
alkaline and acidic conditions. [65]. In a series of macrocyclic uracilophanes with different spacer 
rigidity, it was shown that their aggregation behavior is controlled by the molecule geometry; the 
higher rigidity, the lower aggregation capacity, shown by the difference in CMC from 1 mM for 
“monomeric” and multiuracilophane, to 10 mM for cryptand-like uracilophane [66]. Macrocyclic 
scaffold markedly increased the packing parameter up to the value of 1, thereby tuning the model of 
association and morphological behavior of uracilophanes compared to conventional surfactants [67]. 
It was shown that CMC values of pyrimidinic surfactants with ammonium head groups are lower as 
compared to trimethylammonium counterparts of the same hydrophobicity, with CMC decreasing 
upon the transition from acyclic to macrocyclic compounds, replacement of bromide by tosylate 
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counter-ion, and especially with the introduction of long alkyl chain into the pyrimidine fragment 
[66]. The specificity of self-assembly is clearly demonstrated on the example of sulfur-containing 
pyrimidinophane, for which temperature and concentration dependent gelation occurs [68]. The 
potential of these surfactants is in formation of self-assembled soft matter with negatively charged 
matter of interest, e.g., nucleic acids or proteins, with potential to form stable aggregates with 
capacity to control their release and facilitate their intracellular delivery. 
Pyrimidinic amphiphiles cause decrease of the pH of the solution with increasing concentration 
[66]. This phenomenon has been attributed to shielding effect preventing the access of counter-ion to 
the head groups. As a result, high uncompensated charge is accumulated on the surface of aggregates 
that cause the polarization up to dissociation of water molecules in solvate shells of head groups. 
Generated hydroxide ions bind with cationic head groups, while unpaired hydroxonium ions acidify 
the bulk solution [66]. This effect is of importance from the viewpoint of practical application of these 
surfactants, since it opens the possibility to design the pH controlling nanocarriers bearing uracilic 
moieties. Indeed, for these compounds, stimuli responsive aggregates are obtained that demonstrate 
diverse structural behavior and controlled uptake and release of hydrophobic guest and 
characterized of low toxicity [69]. 
2.3.2. Lipoaminoacids 
In an effort to limit environmental burden and toxicity, synthesis of amino acid-residue 
containing QACs has been proposed. The structure varies from monomeric, alkylated amino acids, 
to gemini QACs [53,70]. Alkylated amino acids comprise a hydrocarbon tail linked either via lysine 
α-amino group or via ε-amino group. Perez et al. observed that QACs belonging to Nε-acyl-lysine 
generally showed decreased hemolytic activity in comparison to Nα-acyl lysine QACs (1g) (Figure 1) 
[71]. Increasing chain length of the alkyl tail resulted in compounds with higher hydrophobic 
component and subsequently lowers the CMC [71].  
Gemini lipoaminoacids comprise two amino acid residues linked by a spacer either via amino 
acid carboxyl group [72] or via Nα quaternary ammonium [53]. Gemini analogs functionalized with 
amino acid moieties demonstrate superior surface activity, and some derivatives promote 
transfection efficacy upon their conjugation with liposomes [48]. Alkylated lauryl arginine monomer 
and gemini with short (C6) spacer assemble into micelles; compounds with longer spacer (C9, C12) 
form vesicles. Diacylglycerol arginine derivatives also showed capacity to form vesicles on their own 
or integrate liposomes consisting of phospholipids. Examples of amino-acid residue containing 
QACs are given in Table 1. 
Most of lipoaminoacids show mild antibacterial activity, serine-based lipoaminoacids were 
successfully tested for DNA complexation. Lysine-based and serine-based lipoaminoacids also 
showed capacity to enhance skin penetration of model drugs encapsulated in liposomes containing 
these compounds [73,74]. Despite these interesting properties, most lipoaminoacids maintain the 
issue of interaction with cell membranes, leading to hemolysis, frequently already at doses required 
for inhibition of bacterial growth. This limits the use of lipoaminoacids to topical use, still making 
them a promising group of novel disinfectant agents or skin permeation enhancers. As evidenced by 
Tavano et al. [72], incorporation of further lipid component, namely cholesterol (Chol) or 
phospholipids, can limit the hemolytic activity of arginine-based QACs (1h) (Figure 1) while the 
antimicrobial activity is preserved; making this class of surfactants active against bacteria at 
concentrations below those at which hemolysis occurs. Further insight on lipoaminoacids, not limited 
to cationic amphiphiles, can be found in work by Bordes and Holmberg [74]. 
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Table 1. Examples of amino-acid residue containing quaternary ammonium compounds 
(QACs). 
Amino 
Acid Type of QAS Type of Aggregates References 
Alanine  Gemini ester quat surfactants / [53] 
Arginine 
Alkylated Arg (LAM), gemini alkylated Arg 
(C6(LA2); C9(LA2), C12(LA2)) 
















2.3.3. Other QASc Containing Natural Moiety: Peptides, Diterpenoids  
Surfactant-like pseudopeptides comprise few hydrophilic head groups originating in amino acid 
residues and a hydrophobic tail. Compounds of this structure have capacity to self-assemble into 
various colloidal structures, including vesicles, nanotubes, micelles, or nanofibres. Synthesis of 
pseudopeptidic cationic amphiphiles has been reported, whose admixtures with anionic component 
form supramolecular biocompatible thermogels with potential applications in cosmetic and 
pharmaceutical products [79].  
Novel amphiphilic diterpenoid derivatives have been synthesized showing structural behavior, 
capacity of integrating with lipid bilayer, and binding with oligonucleotide have to be solely 
controlled by the nature of the counter-ion, i.e., bromide or tosylate ion. While tosylate derivative 
displayed typical behavior and formed micelle-like aggregates, bromide analog underwent structural 
transitions at a certain concentration. Importantly, only the bromide derivative, one of two, could 
penetrate through the membranes. Much attention has been paid to the biocompatible and 
ecologically safe hydrogels that are assumed to result from synergetic contribution of hydrophobic 
effect, hydrogen bonding, and π-stacking interactions [80].  
3. Self-Assembling Strategies for Construction of Soft Nanomaterials for Biomedical Application 
Soft materials are widely used for the modification of drug delivery and targeting [81,82]. First 
of all, these systems can be used for the development of aqueous formulations loaded with poorly-
soluble drugs. Many different drug delivery systems have already been tested, e.g., nanoemulsions, 
hydrogels, microspheres, liposomes, micelles, nanoparticles, and nanocrystals. Recently, many 
efforts have been taken for the development of biocompatible nanocarriers with colloid phase for 
hydrophobic molecules [83], which allow for balancing between advanced efficacy and low toxicity. 
The ultimate aim is to address the demand of pharmaceutical industry, which require novel 
formulations with multiple functionality and diverse types of carriers for controlled binding/release 
of drugs, minimization of biodegradation and side effects, and improvement of bioavailability [84].  
QAC form colloidal aggregates of interest for pharmaceutical industry, applicable for delivery 
of small molecule active ingredients, peptides, and nucleic acids. Micelles and vesicles formed by 
QAS alone or in combination with neutral or oppositely charges surfactants are of interest for their 
increased solubilization capacity, especially for hydrophobic drugs (see further). Cationic stabilizing 
agents are also of crucial important for lipid based colloidal carriers, where they act as stabilizers and 
provide positive overall surface charge. Furthermore, inorganic nanomaterial synthesis often relies 
on use of cationic surfactants as templates. 
Analysis of recent literature testifies that due to their structural diversity cationic surfactants 
tend to form different morphological systems from micelles to vesicles, with the stimuli responsibility 
observed [85]. This is especially manifested in case of cationic geminis, for which size and 
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morphology strongly controlled by structural characteristics, as well as catanionic surfactants 
demonstrating unique morphological and rheological behavior [27]. These properties are responsible 
for the versatile functionality of cationic surfactants and their wide application in modern 
nanotechnologies as modifiers of soft multifunctional nanocontainers (liposomes, nanoemulsions, 
and solid lipid nanoparticles) and metal nanoparticles improving their stability and functional 
activity [10,86,87]. In this review, we emphasized the advantages of cationic surfactants as 
nanocarrier modifiers allowing to (i) increase their colloidal stability; (ii) improve the encapsulation 
efficacy and loading capacity; (iii) increase the affinity toward both therapeutic loads and cell 
membranes; (iv) improve the penetrating through biological barriers, to provide conditions for 
multidrug delivery; and (v) extend markedly the spectrum of their activity due to introducing 
additional functionality, e.g., antimicrobial properties, gel-like or liquid crystalline behavior, and 
catalytic effect. Meanwhile, one of the key challenging tasks in these fields is to achieve a delicate 
balance between the advanced functional characteristics of modified nanosystems and possibly 
unfavorable changes in toxic properties. These points were illustrated by the widely used 
nanocarriers, such as liposomes, nanoemulsions, and metal ion nanoparticles. 
3.1. Aggregates of Oppositely Charged Surfactants: Catanionic Systems 
The use of binary drug delivery systems based on cationic/anionic surfactant mixtures offers 
many advantages [27,88]. These systems are characterized by a diverse morphological behavior and 
demonstrate a high synergetic effect due to the strong negative interaction parameter β. The so-called 
catanionic vesicles are spontaneously formed therein under non-stoichiometric ratio, which is 
governed by both favorable enthalpy changes contributed by high electrostatic attraction between 
head groups and an increase in entropy contributed by release of counterions. Catanionic vesicles are 
superior over typical lipid-based liposomes, since they need no extrusion or sonication treatment; 
show long-term stability and reduced cytotoxicity compared to single constituents; and can be easily 
modified in their size and charge character. Besides structural diversity, gel-like and viscoelastic 
behavior can be easily attained in catanionic systems [89,90]. 
Electrostatic interactions between cationic and anionic surfactants yield amphiphilic ionic pairs 
that may form aggregates of different morphologies with varied shape and size, e.g., spherical and 
rod-like micelles, disk-shaped aggregates, and vesicles [91,92]. Tests on cytotoxicity confirmed that 
catanionic mixed compositions could more effectively cell uptake of cancer cells [82]. Catanionic 
vesicles based on anionic surfactant sodium dodecyl sulfate (SDS) and cationic surfactant CTAB have 
been obtained and used for insulin delivery [93]. Spontaneously formed catanionic vesicles based on 
lactose can upload the hydrophobic phthalocyanine and improve antitumor effect [94]. Simple design 
of the light-sensitive vesicles, commercially available and relatively inexpensive, can be used as a 
new class of rheological fluids with the light-controlled properties [95]. 
3.2. QASs in Role of Stabilizing Agents 
3.2.1. Cationic liposomes 
Liposomes are drug carriers with the large-scale application, with the cationic liposomes widely 
used as transfection agents. It was documented that liposomes bearing positive surface charge were 
selectively cumulated in endothelial tumor cells. In the case of cationic niosomes, their uptake by the 
cells in rat retina and brain was more effective and selective as compared to their uncharged 
counterparts [96]. Multifunctional cationic liposomes based on gemini surfactants and a helper lipid 
dioleoyl phosphatidylethanolamine (DOPE) were successfully used for the co-delivery of RNA and 
doxorubicin into cells [97]. Liposomes fabricated on the basis of diacyl glycerol-arginine surfactant 
and a helper lipid dipalmitoylphosphatidylcholine (DPPC) loaded with ciprofloxacin and 5-
fluorouracil show antibacterial activity, and therefore these formulations were supposed as the dual-
purpose preparations [70]. Liposomes modified with cationic double-chained surfactant 
didodecyldimethylammonium bromide (DDAB), Chol, and non-ionic surfactants were fabricated for 
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delivery of water-insoluble drug curcumin, which improved cell uptake of the carriers compared to 
DDAB-free formulations [98].  
It is known that liposomes admixed with cationic surfactants demonstrate improved 
transdermal delivery of some drugs. Negative charge of skin surface favors the penetration of 
positively charged carriers thereby facilitating the transdermal drug transport. This is exemplified by 
the data on improved transdermal delivery of drug meloxicam by the modification of liposomes with 
cationic surfactant cetylpyridinium chloride [99]. Nogueira et al. described a formulation based on 
novel biocompatible amino acid-based surfactants (natural cationic lipids) that form vesicles, with 
their cytotoxicity controlled by the structure of surfactants [75,100]. 
3.2.2. Nanoemulsions 
One of the most common drug delivery systems that has found numerous practical applications 
are the nanoemulsions. Usually, these systems stabilized with synthetic surfactants. For this purpose, 
novel promising cationic diamidequat-type surfactants are designed with improved biocompatibility 
[101], accomplishing the demands for pharmaceutical and cosmetic use. Bionanoemulsions produced 
with the help of cationic and non-ionic poloxamers were used for improving the antioxidant activity 
of natural phenolic antioxidant curcumin [102]. Block ionomer complexes formed by poly (ethylene 
glycol)-block-poly(4-vinylbenzylphosphonate) (PEG-b-PVBP) and cationic surfactants was used for 
encapsulation of doxorubicin and its controlled release [103]. Spontaneously self-assembled 
nanosized particles are stable over wide variety of experimental conditions and highly sensitive to 
the structure of cationic surfactants. Modification of polymer matrix of contact lenses with cationic 
surfactants (benzalkonium chloride, cetalkonium chloride), proposed by Bengani et al. [104], allows 
to prolong therapeutic modality of ophthalmic drug dexamethasone 21-disodium phosphate 
adsorbed at modified surfaces.  
3.3. QASs in Role of Inorganic Nanomaterial Synthesis  
Numerous promising nanomedicine applications involve metal nanoparticles (NP), therefore 
the synthesis, functionalization, and stabilization of NP is an important task. Cationic surfactants are 
widely used in synthetic protocols, surface decoration, and stabilization of NP [25,105]. Typically, 
reverse microemulsions are used as nanoreactors allowing for the fabrication of particles with 
controlled morphology and size and preventing their undesirable agglomeration. The composition 
of microemulsion, especially the nature and concentration of surfactants markedly affect the 
properties of NP fabricated. This is exemplified by the synthesis of silver nanoparticles in reverse 
microemulsion stabilized with surfactants of different types. The charge character is shown to control 
the size of NP, with admixture of cationic surfactant exhibiting a stabilizing effect. Much attention 
has been paid to the structure-activity correlation [44], which makes it possible to optimize synthetic 
protocols and modify the properties of NP. Imidazolium gemini surfactant capped silver NP have 
been synthesized by Datta et al. [44]. Spacer length is reported to control the morphology of NP, 
which varied from elongated nanostructures in the case of short spacer composed of two methylene 
groups, to spherical one in the case of longer spacers (five to twelve methylene units). Importantly, 
not only the structure but also the orientation of surfactant molecules may affect the properties and 
functionality of NP [106]. Imidazolium gemini surfactant coated gold NP were efficient in piroxicam-
loading and sustained its release, as the gemini surfactant formed a bilayer on NP surface, providing 
suitable environment for drug loading while not exceeding the cytotoxicity observed when using 
different cationic surfactants [107]. Synthesis of mesoporous silica NP by Stober method relies on 
hydrolysis of organoalkoxysilane in presence of CTAB. More details into silica NP synthesis methods 
and used can be found elsewhere [108,109]. 
4. Quaternary Ammonium Surfactants in Pharmaceutical Applications 
Several current and prospective pharmaceutical dosage forms gain considerable advantage over 
neutral or negatively charged drug delivery systems when they present overall cationic charge. This 
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is the case of colloidal systems aimed for ocular drug delivery, where positively charged aggregates 
interact with negatively charged ocular surface and hut provide longer contact time, resulting in 
improved ocular bioavailability of the administered drug and provide a base of long-time, prolonged 
release of the drug [24]. An improvement of skin penetration was reported after application of 
cationic amphiphiles, mainly amino-acid based [73,76,78,99]. Most importantly, cationic amphiphiles 
improve drug loading of many actives into pre-existing drug delivery systems (liposomes, hydrogels, 
and lipid particles) or improve substantially their solubility by complexing the drugs into self-
assembled colloidal aggregates, micelles or vesicles.  
4.1. Delivery of Small Drug Molecules  
QAC often show superior drug solubilization efficacy than neutral materials. In part, this is due 
to amphiphilic character of QACs, frequently beneficial for formulation of hydrophobic drugs. 
Improved solubilization capacity then results in higher encapsulation efficacy of drug delivery 
system in question. Furthermore, inclusion of cationic amphiphiles has impact on drug release. 
Smart delivery systems based on cationic surfactants have been designed and used for controlled 
binding/release of antibiotics, doxycycline and oxytetracycline [110]. The pH sensitive drugs can be 
selectively bound within nonpolar core (zwitterionic form of drug) or in cationic shell (anionic) form 
depending on the pH of the solution, while the release of drug was magnesium driven process. 
4.1.1. Factors Determining the Solubilization Efficacy 
Efficacy of micellar solubilization depends on numbers of factors, such as structure of 
surfactants, aggregation number, morphology of aggregates, ionic force, temperature, as well as on 
the structure of the solute. An increase in the alkyl chain length of cationic surfactants with trimethyl 
ammonium head group is shown to result in the linear increase in the solubility of hydrophobic dyes. 
This may be explained by an increase in nonpolar core of surfactant aggregates. Gemini surfactants 
demonstrate enhanced solubilizing properties as compared to monomer analogs. This is probably 
promoted by the lower CMC of gemini surfactants. The nature of counter-ion slightly influences the 
solubilization capacity of aggregates. On the other hand, the nature of head groups (e.g., non-ionic 
versus ionic and imidazolium versus trimethyl ammonium) has been reported to markedly affect the 
solubilization efficacy of surfactants [111,112]; in particular the ability of interactions between the 
head groups and solutes strongly facilitates the solubilization power. This means that binding of the 
probe occurs not only within the nonpolar core but also by the periphery, as for example in the case 
of non-ionic surfactants that have polyoxyethylene mantle [111]. On the other hand, the study of 
cationic systems testifies the existence of cation-π as well as π-π interactions between drugs and 
surfactant (dopamine hydrochloride or and acetylcholine chloride and 1-tetradecyl-3-
methylimidazolium bromide) [112].  
Among ionic surfactants, the cationic surfactants show superior solubilization capacity toward 
polyaromatic hydrocarbons, such as anthracene and pyrene, which is due to the favorable 
electrostatic interactions between the positively charged head groups of amphiphiles and electron 
donating aromatic rings [113]. The use of mixed systems based on gemini and conventional 
surfactants makes it possible to stabilize micelles and enhance the solubility of poly polycyclic 
aromatic hydrocarbons (naphthalene, anthracene, and pyrene) [114]. The solubilization study of 
naphthalene and stearic acid demonstrated that trimeric surfactant presented better potential as 
solubilizer compared to typical monomeric and dimeric surfactants [115]. 
4.1.2. Drug-Amphiphile Interactions 
Amphiphilic molecules and drugs can form mixed assemblies that result in the increase in the 
solubility, stability, and bioavailability of drugs and concurrently, in changing in the micellization 
process [116]. Different morphology of resulting mixed systems can be used for controlled release of 
loads for the derivatives of cephalosporin, the mutual influence of surfactant and drug is evaluated, 
in particular, the CMC of cationic surfactants are shown to increase with the drug added [117]. The 
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influence of cationic surfactant cetyltrimethylammonium bromide on the spectral characteristics and 
acid-base properties of the drugs irbesartan, losartan, and valsartan has been recently demonstrated. 
The interaction of losartan with CTAB is followed by an increase in the absorbance of the drug and 
shift of pKa. This specific interaction allows for sensitive quantification of drugs in complex 
pharmaceutical formulations [118].  
Amphiphilic surfactants have also been used for formulating amphiphilic drugs and, in this case, 
the probability of producing mixed assemblies markedly increases. For the system based on 
amphiphilic drug promethazine and cationic imidazolium surfactants thermodynamic parameters 
have been estimated which testified that synergetic effect occurred, thereby supporting the formation 
of mixed aggregates with higher stability and more compact packing of monomers. Along with 
electrostatic interactions, the contribution of hydrophobic effect has been emphasized, which was 
exemplified by the imidazolium surfactant-ibuprofen system [119]. The structure of aggregates of 
ionic liquids based on imidazolium salts and surface-active drug (e.g., ibuprofen) may be controlled 
by the variation of alkyl chain length of cationic surfactant [58]. In a mixture of ibuprofen and cationic 
surfactant with short tail, spherical micelles are reported to be formed. An increase in the alkyl chain 
length of imidazolium surfactant results in an increase in the size of micelles. Meanwhile, within the 
low concentration range the formation of vesicles has been observed. The development of a new 
strategy for the fabrication of double-wall nanotubes of different morphology by the mixing of two 
oppositely charged antitumor drugs has been reported [120]. Preliminary animal testing showed that 
these nanotubes markedly prolong the contact of drug with tumor cells.  
4.2. Protein and Peptide Delivery and Peptides for Drug Delivery 
4.2.1. Protein and Peptide Delivery by Cationic Surfactants 
With respect to protein-surfactant interactions several factors should be taken into account, e.g., 
the charge of head group, the length of hydrophobic fragment, and the conformation of protein. 
Conformation changes of the proteins upon their binding with surfactants influence the functional 
activity of the proteins and provide the molecular level information on the protein-surfactant 
interactions. The binding interactions of the surfactants with bovine serum albumin (BSA) were 
exemplified by computer simulation the results disclosed that the surfactants bound stably between 
hydrophobic subdomain IIA and IIIA where tryptophan-213 residue [121]. In the case of gemini with 
pyridinium group, conformation changes are due to the π-stacking interactions of pyridinium ring 
of the surfactant and pyrrole ring of tryptophan residue of BSA [122]. The role of micellar medium is 
equally important in drug-protein the interactions [123]. The binding strength of drug diclofenac with 
BSA increases if the preparation is used in micellar formulation based on cationic surfactant.  
4.2.2. Drug Delivery by Quaternary Ammonium Containing Peptides 
The powerful tool for the intracellular delivery of different therapeutic molecules is the 
conjugation of therapeutic cargo with the cell penetrating peptides (CPP). They are regarded as 
promising transporters for a variety of biomolecules with low bioavailability across the lipid bilayer. 
Positively charged arginine-rich cell penetration peptides were successfully used as vectors for the 
intracellular transport of small bioactive molecules involving endocytosis as a key cellular uptake 
pathway [124]. An effective strategy for improving the cellular uptake consists in attachment of short 
hydrophobic fragment, the so-called penetration-accelerating sequence to arginine-rich CPP. The 
important role of the hydrophobicity of the CPP-conjugated formulation was particularly 
emphasized [124]. Ye et al. developed a simple method for the intracellular delivery of negatively 
charged phosphopeptides through their non-covalent conjugation with cationic vector based on 
amphiphilic tripodal peptide analogues [125].  
An effective peptide-based strategy was developed by Cheetham et al. [126], in which 
amphiphilic drug molecules were designed through conjugation of hydrophobic drug camptothecin 
with Tau-β-sheet-forming peptide. Resulting nanostructures are reported to be characterized by high 
loading capacity and controlled drug release, which allows this protocol to be extended for delivery 
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of related drugs. Improved mitochondrial targeting behavior was achieved in the study [127], which 
reported on the dual conjugation strategy consisting in the combination within a molecule of both 
CPP and a targeting agent. These conjugated carriers show superior intracellular delivery of 
therapeutic unit with low penetrating ability across the membrane. Meanwhile the use of single 
transporter molecules, CPP, or mitochondrial targeting sequence appeared to be less effective. 
4.3. Gene Delivery  
Nucleic acid molecule typically cannot enter the cell on its own. Currently, it is recognized that 
a successful non-viral, intracellular nucleic acid delivery system is dependent on a cationic 
component (e.g., [128]). This is responsible for DNA/RNA condensation and packing, and for initial 
contact of gene delivery system with cell surface, which has overall negative charge, originating from 
phosphate groups of various phosphatidylcholines. Cationic agents (polymers or lipids) show high 
affinity for the phosphate backbones of DNA. In order to condense and deliver nucleic acids 
effectively, lipoplexes typically require presence of a helper lipid in the formulation. As helper lipid, 
DOPE is used more frequently, and is included in various commercial transfection reagents. 
Dimyristoylphosphatidylcholine (DMPC) or Chol can also act as helper lipids. Despite availability of 
several cationic lipid-based transfection reagents, none of it is suitable for clinical use due to its 
toxicity (mainly hemolysis and potential of trigger of immune system reactions). Therefore, synthesis 
of new cationic agents with increased DNA binding efficiency and decreased toxicity potential is a 
lively field with possible great impact on translation of gene delivery from non-clinical to clinical 
applications. 
Efforts have been made to design novel QAS for gene delivery that would be able to deliver 
nucleic acids without complementary action of helper lipids. Inspired by rigid, planar structure of 
Chol, Andrzejewska et al. synthetized cationic gemini surfactants that comprise a rigid cyclic moiety 
and condensed DNA of various length into stable aggregates, being the surfactant with longer spacer 
slightly more efficient in DNA binding [129]. 
Cardoso et al. reported that 12-5-12 and 12-10-12 QAS complexed DNA successfully but their 
transfection efficiency was low, even in the presence of helper lipids, and toxicity towards cells was 
observed [130]. As an alternative, serine based cationic gemini surfactants series with different alkyl 
chain length and amine, amid, or ester groups linking the serine moieties with the spacer, were 
successful in DNA binding and showed efficient in vitro transfection, without marked decreased of 
cell viability. The nature of linkage between head-group and spacer influenced markedly DNA 
release, being the ester bond containing surfactants the least prone to release DNA upon contact with 
vesicles mimicking cell membrane [48]. 
Cationic amphiphiles bearing pyrimidine fragment have been explored with the aim of 
highlighting the role of complementary interactions involving pyrimidine moiety of amphiphiles and 
nucleotide bases of DNA. Among them bola-form, single-head, and dicationic pyrimidinic 
surfactants were used, which enable us to differentiate the contribution of electrostatic and 
hydrophobic interactions to the DNA-surfactant complexation [131]. It has been shown that dimeric 
pyrimidinic gemini with enhanced hydrophobicity and high micellization capacity demonstrated 
highest condensing activity exceeding that of conventional m-s-m geminis and bola-form analogs. It 
was shown that complexation activity of surfactants toward oligonucleotide increases from 
ammonium surfactants < phosphonium surfactants < 1,4-diazabicyclo[2.2.2]octane based surfactants 
[132]. Gemini pyrimidine surfactant (SPYRIT 68) showed better in vitro transfection efficiency than 
monomer cationic lipid (SPYRIT 7), but also higher cytotoxicity. A combination of both cationic lipid 
and gemini surfactant showed even better transfection efficiency and decreased cytotoxicity. A 
possible mechanism of action was the induction of endolysosomal membrane rupture, induce by 
gemini SPYRIT 68, documented by diffuse intracellular distribution of Rab-7, a Rho-GTPase present 
on late endosomal membrane [133]. 
In a series of hydroxyethylated analogs of m-s-m geminis, i.e., 16-s-16 (OH), with m varying 
between four, six, and 12, the spacer length markedly influenced the transfection efficacy. The 
maximum transfection was observed in the case of the longest spacer [134]. 
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4.4. Antimicrobial Effects 
Due to the ability of interaction with cell membranes, namely attraction by overall negative 
charge of the membrane and insertion, cationic amphiphiles facilitate contact with cell surfaces and 
intracellular delivery of the cargo. Frequently, the interaction of cationic amphiphiles leads to 
perturbation of membrane, and, ultimately, may lead to membrane rupture. Disruption of cell 
membrane integrity by cationic surfactants seems to affect both prokaryotic and eukaryotic cells. 
Hemolysis is therefore often used as proof of cationic amphiphile interaction with eukaryotic 
membrane [72,76], but in practical terms it excludes many interesting cationic amphiphiles for the 
use for which they were designed. Apart from cell membrane damage, CTAB is known inductor of 
oxidative stress, even when incorporated in lipid nanoparticle systems that shield partly its effects 
on cell [105]. 
Combination of cationic amphiphiles with helper material might shield their toxic effects 
towards cell membranes, but this may not be sufficient for clinical use. Therefore, use of cationic 
amphiphiles is often limited to local administration, where they already showed interesting 
properties, namely in ophthalmic applications and for skin penetration enhancements. Furthermore, 
antimicrobial activity that cationic amphiphiles exert makes them suitable candidates for topical 
disinfectants and antiseptic agents. Tavano et al. reported that a series of arginine-based cationic 
gemini surfactants, incorporated in liposomes, showed antimicrobial efficiency (represented by 
inhibition concentration for 50% of bacteria, IC50) at concentrations lower than those at which 
hemolysis occurs [72]. Dialkylamino and nitrogen heterocyclic analogues of 
hexadecylphosphocholine and CTAB showed strong cytotoxic activity against several cancer cell 
lines, fungi (antifungal activity) and protozoans (antiprotozoan activity), all at concentrations much 
inferior to those at which hemolysis was observed, being the most active compound, in terms of 
cytotoxicity, a dibutylamino analogue of CTAB [135]. 
Colloidal complexes of cationic surfactants with negatively-charged hyaluronic acid (HyA) were 
found to reduce the cytotoxicity induced by surfactants. the specific sensitivity of different cell types 
to surfactant treatment was determined [136]. Dequalinium is another example of a QAC that despite 
interesting antimicrobial properties cannot be used for systemic infection treatments but found 
application in treatment of topical infections. Dequalinium forms vesicles, DQAsomes, which allow 
for encapsulation of further antimicrobial agents [137]. 
5. Self-Assembled Quaternized Derivatives of 1,4-Diazabicyclo[2.2.2]Octane and Quinuclidine 
Our group is focused on the development of polyfunctional systems based on the diversity of 
cationic surfactants. Among them, much attention has been paid to quaternized derivatives of 1,4-
diazabicyclo[2.2.2]octane and quinuclidine (Q-Nuc-n). These amphiphilic compounds can be 
obtained through the simple synthetic route, i.e., the quaternization of DABCO by alkyl bromides. 
The bicyclic precursor, DABCO, is a commercial product that is widely used as catalyst. Saturated 
bicyclic scaffold with a single junctional nitrogen (quinuclidine) is common in natural physiologically 
active substances. This primary bicyclic compound provides many advantages for the design of 
amphiphilic compounds with diverse structural behavior, involving one to four nitrogen’s bearing 
alkyl groups of different hydrophobicity [138]. Quaternized derivatives of 1,4-
diazabicyclo[2.2.2]octane (DABCO-n series) are of special interest, because of their wide applications 
including their use as antibacterial agents (e.g., [139]) and artificial ribonucleases [140]. Despite the 
key role of hydrophobicity of surfactants in their micellization and functional activity, this aspect is 
poorly studied for alkylated DABCO excepting isolated publications. Our work focused on the 
aggregation activity of mono-(3) and di-(4) and tetracationic (5) derivatives of DABCO (Figure 2) in 
water, chloroform, and biological fluids [138,141,142], their catalytic and biological activity [142,143], 
adsorption on the air/water interface [141,144] in both single solution and in the presence of 
calixarenes [145–147], organophosphorus substrates [148–150], and polymers [151]. As can be seen 
from the structural formulas (Figure 2), these surfactant series allow the comparison of the behavior 
of gemini surfactants bearing two charged fragments and two long-chain alkyl groups with dicationic 
surfactants bearing one long-chain alkyl fragment. 
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Figure 2. Structural formulas of quaternized derivatives of quinuclidine (1a–d) and monocationic (1,4-
diazobicyclo[2.2.2]octane (DABCO)-n) (3a–d), dicationic (Et-DABCO-n) (4-Et a–d), (C2H4OH-
DABCO-n) (4-C2H4OH a–d), (4-C2H4OC6H5 a–d), and tetracationic gemini n-DABCO-2-Dabco-n (5a–
d) surfactants. 
5.1. Aggregation Behavior and Morphology 
The use of cationic surfactants in the biomedical field requires the assessment of their 
aggregation parameters (i.e., CMC, aggregation number, Nagg, hydrodynamic radius/diameter of 
aggregates, RH/DH, degree of counter-ion binding, and (β)) which are usually determined by different 
techniques summarized in Table 2. The data demonstrate that CMC values depend both on the 
hydrophobicity and number of charge fragments of surfactants. An increase in the number of carbon 
atoms in alkyl groups (n) results in a predictable decrease in CMC in accordance with a linear 
dependence: 
 (1)
where a and b are constants for a for a particular homologous series and temperature. Dicationic 
single-tailed surfactants, diquaternized derivatives (4) show higher CMC as compared to 
monocationic (3), and acyclic (CTAB) analogs (Table 2) (Figure 3). There is a good linear dependence 
for all Dabco-surfactant series. 
−log CMC = 1.25−0.28n r2 = 0.997 (for Q-Nuc-n) (2)
−log CMC = 1.33−0.27n r2 = 0.998 (for mono-DABCO-n) (3)
−log CMC = 1.52−0.25n r2 = 0.997 (for di-DABCO-Et-n) (4)
−log CMC = 0.77−0.23n r2 = 0.999 (for geminis tetra n-DABCO-s-DABCO-n) (5)
Slopes are decreasing from monocationic DABCO-n (0.27) to dicationic Et-DABCO-n (0.25) and 
tetracationic n-DABCO-2-DABCO-n (0.23) surfactants. Characteristic slope is 0.28–0.30 for typical 
ionic surfactants. This behavior is associated with an increase in the number of charged nitrogen 
atoms and polarity of DABCO-surfactants. The CMC of tetracationic n-DABCO-2-DABCO-n are 
higher than CMC of monocationic DABCO-n and lower than dicationic Et-DABCO-n with the same 
alkyl chain. This can be due to the strong electrostatic repulsion of two similarly charged nitrogen 
atoms, which is not compensated by hydrophobic effect contributed by second alkyl tails as in the 
case of geminis. 
( )bnaCMC +=− log
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Figure 3. The effect critical micelle concentration (CMC) on chain length (n) and amount of charge of 
cationic surfactants based on DABCO and quinuclidine, quinuclidine (Q-Nuc-n) (1), mono-DABCO-
n (2), di-DABCO-Et-n (3), and tetra n-DABCO-s-DABCO-n (4) 25 °C. 
Additives are shown to affect the CMC values. For aqueous 3c solution the influence of water-
soluble calix [4] resorcine [138,145,146], organic electrolytes (sodium salicylate (NaSal), sodium 
tosylate (NaTos), sodium benzoate (NaBn)), and polyelectrolyte (sodium polystyrene sulfonate, PSS) 
[152] capable of self-assembling are used. A significant decrease of CMC in the presence of salts was 
found. The addition of CR groups promotes the formation of mixed aggregates. Recently we have 
reported about the substantial decrease in CMC of 3c and 4c in nutrient broths (Hottinger broth (рН 
= 7.2) and Sabouraud dextrose broth (рН = 5.6)) up to 60 times [142]. 
Apart from CMCs, the degree of counter-ion binding β, radiuses of quaternized DABCO 
derivative aggregates and number of aggregations are determined. For 3a, 3b, and 3d, β ranges from 
0.67 to 0.84, while for 3c it changes from 0.81 to 0.91 [144]. NMR diffusivity data reveal that around 
the CMC hydrodynamic radiuses equal 15.1, 20.3, and 22.8 Å, while aggregation numbers equal 24, 
54, and 72 for 3a, 3b, and 3c, respectively [149,153], i.e., both parameters increase with the 
hydrophobicity of surfactants. For concentration range above CMC the radiuses and aggregation 
numbers were shown to depend on the surfactant concentration [154]. At high 3b concentrations the 
larger micelles are formed that are characterized by higher numbers of aggregation. This is confirmed 
by the fluorimetry data indicating that for the 3b concentrations of 5 × 10−3, 7.5 × 10−3, and 2.5 × 10−2 M 
aggregation numbers equal 40, 59 and 114, respectively. 
3c has been shown to belong to amphotropic compounds capable of forming the mesophase of 
different types, i.e., thermotropic and lyotropic. It has been found that for lyotropic liquid crystals 
the wider temperature range is observed as compared to thermotropic phase. The existence of 
lyomesophase within the wide temperature range extends the application of these systems as matrix 
for the design of nanomaterials and models of membranes in biotechnological protocols. These data 
are in line with unusual structural behavior of hydrophobized DABCO derivatives highlighted by 
the dynamic light scattering data. For 3d ensembles, hydrodynamic diameter has been recorded in 
the range from 180 to 280 nm and was dependent on the age of the solutions. An increase in the 
concentration of 3c was followed by the decrease in the size of aggregates from 180 to 135 nm. The 
hydrodynamic diameter of 4-Et particles at concentration around CMC is ca. 110–160 nm. The 
monitoring of the solutions with time revealed even higher aggregation of particles. The increase in 
the concentration of 4-Et was followed by the substantial decrease in the size of aggregates, up to 3–
4 nm [141]. Similar decrease of particle size takes place for tetraquaternized derivatives of DABCO. 
This phenomenon can be due to the change in the morphology of aggregates, e.g., the predominant 
existence of vesicle structures in the range before and near CMC, with their transfer or organize at 
the same time more compact micellar form with the growth in surfactant concentration. The 
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fluorescence anisotropy of 1,6-diphenyl-1,3,5-hexatriene in 4b solutions supports our suggestions on 
the change of the morphology of aggregates. 
5.2. Solubilization and Controlled Binding/Release of Hydrophobic Guests 
Solubilization capacity of aggregates is a key property responsible for the use of cationic 
surfactants as nanocarriers. This stimulates the search for novel effective formulations for 
solubilization of hydrophobic drugs and diagnostic probes, and therefore the elucidation of 
structure-activity relation is a challenging task. While the factor of hydrophobicity of surfactants in 
terms of alkyl tail length is discussed in literature, the influence of structure of head groups is less 
studied and understood [155]. In our work [156], the higher solubilization capacity toward 
hydrophobic dye Orange OT is revealed for quaternized DABCO as compared to trimethyl 
ammonium analogs (Figure 4).  
 
Figure 4. The solubilization capacity of micellar aggregates based on quaternized derivatives of 
DABCO and trimethyl ammonium (TMA) analogs toward the dye Orange OT. 
Solubility of Orange OT linearly increases with alkyl chain length of surfactants and follows the 
relations: 
S = −0.0197 + 0.00215n, r = 0.997 (for TMA) (6) 
S = −0.0899 + 0.00843n, r = 0.997 (for mono-DABCO-n)  (7) 
S = −0.0442 + 0.00413n, r = 0.997 (for di-DABCO-Et-n)  (8) 
S = −0.08303 + 0.0066n, r = 0.97 (for geminis tetra n-DABCO-s-DABCO-n)  (9) 
This may be explained by the fact that regardless of the similarity of CMC values for trimethyl 
ammonium-n and DABCO-n series, their structural behavior differs markedly. Moreover, DABCO 
based cationic surfactants exhibit superior solubilization properties over cationic surfactants with 
triphenylphosphonium head groups [155], although the latter are characterized by advanced 
micellization activity, i.e., their CMCs are ca. 10-fold lower compared to that of DABCO-series. 
Different effect of the hydrophobicity factor occurs in the case of trimethyl ammonium and DABCO 
series. An increase in alkyl chain length of surfactants exerts much more marked effect on the 
solubilization capacity of DABCO surfactant as compared to trimethyl ammonium series. 
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Table 2. Values of CMC of cationic surfactants in water. 
Surfactant Additives 
CMC × 103 (M) (based on different techniques) 
Refs 
Tensiometry Conductometry Potentiometry NMR Fluorimetry Spectrophotometry 
2b  2.5 2.85   3.0 1.5  
2c  0.85 0.6   0.94 0.8  
2d  0.2 0.24   0.3 0.3  
3a  11 14 16 15 -  [144,149] 
3b  4.0 3.0 3.7 3.4 4.3  [144] 
3c  1.0 1.0 1.9 0.85   [144,153] 
3d  0.24 0.11 0.22 0.11 -  [144,149] 
4a-Et  26.5 28.4 29.7   28 [157]  
4b-Et  10.3 8.5 8.4  8.1 9.5 [157]  
4c-Et  3.0 3.1 2.0 - - 2.3 [157]  
4c-EtOH  2.0 2.5 3.0 - - - [138,157]  
4d-Et  0.80 0.83 0.98   1.1 [157]  
5b  4.0 3.0 2.0  4.2 3.6 [158] 
5c  1.5 1.7 2.3  0.8 1.7 [158] 
5d  0.5 0.5 0.15  0.29 0.2 [158] 
3c CR-1 2 0.1 - - - - [138] 
4c-Et CR-1 1.5 1.5 - - - 0.8 [138] 
5c CR-1 1 0.4 - - - - [138] 
3c CR-1 0.4 0.1 4.9 0.45 - 5.0 [145] 
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The decrease in solubilization capability of di-CS-n with the same alkyl chain may result from 
their lower aggregation numbers and lower packaging in di-CS-n micelles. 
Many advantages in the development of effective drug delivery systems may be obtained upon 
the design of mixed assemblies. Nowadays, the interest in mixed compositions has markedly 
increased due to the development of novel direction of supramolecular chemistry focusing on the 
formation of supramolecular amphiphiles [159]. Growing interest in supramolecular amphiphiles is 
determined by two aspects [160]: (i) easy design of supramolecular amphiphiles that can be formed 
through various non-covalent interactions (hydrogen bonds, metal–ligand coordination, electrostatic 
and π-stacking, as well as host–guest interactions) [161] and (ii) dynamic character of non-covalent 
associates that enable easy control of the properties of formed structures [162]. The latter is essential 
for the design of smart supramolecular materials, which are responsive to various factors (e.g., рН, 
temperature, light, magnetic field, and oxidation) [163]. The application of mixed surfactant-
calixarene systems opens additional opportunities in this field, since the involvement of macrocyclic 
receptors may provide a high selectivity of the guest binding based on principles of the molecular 
recognition. It is known that macrocycles can take part in guest–host interactions due to the presence 
of molecular cavity and preorganization of functional groups [164]. A key point is that the self-
assembling mechanism of surfactants and calixarenes may be strongly different that provides the 
possibility for the development of nanocarriers with controlled binding/release properties by means 
of inducing the morphological rearrangements. Besides, specific geometry of calixarene molecules 
emphasize their potential as drug delivery systems [165]. 
As mention above in the presence of CR-1, cationic surfactant 3c starts to associate at the lower 
concentration and undergoes further morphological transitions with an increase in the concentration 
[145]. The solubilization study with the use of hydrophobic dye Orange OT demonstrated that only 
mixed aggregates enriched by 3c are capable of binding the organic probe, while mixed system where 
the surfactant is a minor component shows no binding capacity towards Orange OT (Figure 5). This 
finding can be used for the design of nanocarriers with controllable binding-release properties. 
The packing mode, morphology, and size of assemblies and their solubilizing properties depend 
on the structure of cationic surfactants, in particular, their charge character and the ratio of the 
components in mixed system. The key role of electrostatic interactions in the formation and 
rearrangement of mixed supramolecular structures has been demonstrated by Pashirova et al. [138]. 
It was shown that the systems with either the minor or predominant content of cationic surfactants 
exhibit the lowest and the highest solubilizing capacity, respectively, toward hydrophobic organic 
guest. This is essential from the viewpoint of the design of nanocarriers with controlled and reversible 
binding capacity toward therapeutic agents or biomolecules. 
The factor of hydrophobicity is differently displayed in the case of macrocyclic amphiphiles, i.e., 
calixarenes compared to conventional surfactants [166]. Unlike typical surfactants, the influence of 
alkyl chain length on the size and morphology of aggregates, their surface and functional activity 
have critical character, in particular, the change in the association model occurs in the case of R = 
С5H11 (Figure 6). This finding is of key importance from the viewpoint of development of smart 
nanocarriers based on mixture of surfactant and macrocycles. The idea of modification of the 
surfactant-calixarene nanocarriers can be improved by the knowledge of other structural factors 
controlling the morphological behavior and solubilization activity of superamphiphilic 
compositions. The modulation of properties can be achieved by the variation of the nature of 
dispersion media, component ratio, and even the nature of counter-ions [166,167]. 
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Figure 5. Changes in the supramolecular architecture with the variation in the calixresorcine ratio: 
The controllable guest release. 
 
Figure 6. Changes in the morphology with the variation in the surfactants-calixresorcine ratio. 
The data obtained allow anticipating that novel DABCO-based cationic surfactants along with 
geminis may have promising structural units for the design of nanocarriers for gene and drug 
delivery. 
5.3. Supramolecular Catalysis 
One of the challenges in the modern catalysis is the development of artificial catalytic systems 
modelling the elementary mechanisms of enzyme catalysis, which requires the elucidation of factors 
controlling the rate enhancement in living systems. Supramolecular catalysts are assumed to exhibit 
biomimetic character, since their mechanism includes the formation of the substrate-catalyst 
complexes [168], which further undergo chemical transformation, with both stages contributing to 
the change rate. The same mechanism involving the preliminary binding the substrate occurs in 
enzyme catalysis. Therefore, the study of highly effective and selective supramolecular catalytic 
systems may shed light on the factors controlling high efficacy and substrate specificity of 
biocatalysts. The knowledge of these factors and their reproducing in technological protocols are of 
key importance from the viewpoint of criteria of green chemistry, since they make it possible to 
decrease the concentrations of catalysts in a marked extent and hence to fabricate ecologically friendly 
systems [169]. 
At present, the main lines of improvement of micellar catalysts are enhancing the efficiency and 
selectivity of catalytic systems and reducing the surfactant concentration. This can be achieved by 
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varying the surfactant structure, including the nature of the head group, and by passing to dimeric 
(gemini) surfactants. Catalytic activity of the systems based on quaternized derivatives of DABCO is 
exemplified by basic hydrolysis (in water) and aminolysis (in chloroform) of phosphorus acid esters 
(Figure 6) monitored by methods of spectrophotometry [147–150] and NMR spectroscopy [148]. 
These reactions may serve as convenient model for studying of the most important biochemical 
reactions. Moreover, the cleavage of phosphoester bonds is one way of detoxification for 
organophosphorus neurotoxins and toxicants [2]. 
Our studies focusing on the evaluation of the structure-activity relations revealed that the 
cationic surfactants catalyze the hydrolysis of NBCP (Figure 7). Their catalytic activity depends on 
the structure of the head group of the surfactant and increases in the order CTAB ≈ morpholinium 
surfactant < cetylpyridinium bromide < monoquaternized DABCO derivatives. The catalytic effect of 
aggregates of DABCO-surfactants increases with the increase of their hydrophobicity and with the 
decrease of the alkalinity of the solution and can achieve ca. 200 times [149]. Chemical reactions in 
organized solutions containing metallomicelles formed by complexes of metals with the surfactant-
based ligand or involving aggregates solubilizing metallocomplexes with no hydrophobic long chain 
fragment are of special importance. This is due to the fact that such kind of assemblies can show 
enhanced functional activity including catalytic effect, which provides further possibility for the 
design of new materials, destruction of poises and ecotoxicants, and development of biomimetic 
technological approaches. Investigations of the effect of DABCO-surfactant/lanthanum nitrate 
systems on basic hydrolysis of NECP, NPCP, and NHCP revealed the high catalytic effect of more 
than two orders of magnitude [157]. A system based on aminomethylated calix [4] resorcinarene (CR-
1) DABCO surfactant (3c) and their mixtures has shown the catalytic effect on the hydrolysis of 
phosphorus acid esters. It was established that the presence of La(NO3)2 leads to a 650-fold increase 
in the catalytic effect [147]. The presence of La(III) ions enhanced the catalytic effect of calixarene 
aggregates due to complex manifestations of micellar and homogeneous (electrophilic) catalyst, and 
to favorable changes in the characteristics (the degree of binding of counter-ions and surface charge). 
The favorable effect of amphiphilic additives is due to their ability to form individual and mixed 
aggregates in aqueous solutions, the transition of reagent from the bulk solution into these 
aggregates, and the turning the chemical process to the new direction. 
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Figure 7. Scheme of alkaline hydrolysis of phosphorus acid esters. 
5.4. Antimicrobial Activity 
In addition to the aggregation and catalytic properties, antimicrobial activity of quaternized 
DABCO derivatives has also been studied, whereby the correlation of antimicrobial and aggregation 
properties is analyzed [148]. The bacteriostatic activity is decreased with increasing the alkyl chain 
length for DABCO-n from dodecyl to its octadecyl analogue. DABCO-16 and DABCO-18 exhibit a 
highest bacteriostatic activity (MIC = 0.3, 1.9, and 6.3 µg/mL against St. aureus, B. cereus, and E. coli, 
respectively). Generally, bacterial strains were the most sensitive toward 
tetradecylrimethylammonium bromide in series of n-alkyltrimethylammonium bromides [170] and 
toward C14 (for gram-positive bacteria), and C16 (for gram-negative bacteria) in series of 
alkyldimethylbenzylammonium chlorides [171]. The influence of head group is mostly evident in the 
case of St. Aureus, for which the transition from CTAB to quaternized quinuclidine and 
monoquaternized DABCO derivatives provide a tenfold increase in bactericidal activity. Much 
higher antifungal activity exemplified by Tr. gipseum and C. albicans should also be noted for 3d as 
compared to CTAB. Fungistatic activity of 3d toward these strains is by two-fold and four-fold higher 
and fungicidal activity is by 16-fold and 10-fold higher than those for CTAB. The bactericidal and 
fungicidal activity of Q-Nuc-18 is 1.95 µg·mL−1. This value is much higher than for its DABCO-n 
analogues. Q-Nuc-18 has bactericidal and fungicidal activity two times (against St. aureus) and eight 
times (against B. cereus) higher than antibiotics Norfloxacin and antifungal Ketoconazole. Q-Nuc-16 
has the highest bactericidal activity. It is six times (against St. aureus) and 15 times (against B. cereus) 
higher than the bactericidal activity value of Norfloxacin [143]. 
Second charge moiety exerts a negative influence on antifungal activity, e.g., the transition from 
monoquaternized derivatives of DABCO (3c) to diquaternized derivatives of DABCO (4c-Et) results 
in four-fold decrease in antifungal activity toward Tr. gipseum and in ten-fold decrease toward C. 
albicans. At the same time, antimicrobial activity toward B. Cereus, E. coli, and St. Aureus remains 
practically the same. Data obtained demonstrate that the introduction of bicyclic polar fragment into 
surfactant platform may be of interest from the viewpoint of the design of antimicrobial preparations 
(in particular, antifungal ones) of little toxicity. The highest effect can be achieved by the increase of 
alkyl chain length and optimization of hydrophilic-lipophilic properties [148]. In case of tetracationic 
surfactants, 12-Dabco-2-Dabco-12 is the most active without hemolytic activity at concentration 3.1 
µg·mL−1. The MICs of 2-Dabco-2-Dabco-12 are 3.9, 7.8, and 31.3 µg/mL against St. aureus, B. cereus, 
and E. coli, respectively. Likely this is due to a different mechanism of action of these surfactants. 
Four charged nitrogen atoms and two alkyl chains of n-Dabco-2-Dabco-n may accommodate faster 
interaction and penetration of DABCO-surfactants through the bacterial cytoplasmic membrane. 
These results clearly indicate that the antibacterial activity of DABCO-surfactants is strongly affected 
by their structure (alkyl chain length and the amount of charged nitrogen). 
The ways of decreasing the toxicity of biologically active compositions with the preservation of 
their useful properties is an important task. For this purpose, the effect of N-methyl-D-glucamine 
additive on the antimicrobial activity of monoquaternized derivatives of DABCO and its aggregation 
and solubilization parameters has been assessed [142]. Although N-methyl-D-glucamine itself shows 
no biological activity, its addition to DABCO surfactants enables one to decrease the concentration of 
the active ingredient (DABCO surfactants) in antimicrobial composition by two times thereby 
reducing the toxicity of cationic surfactant on human red blood cells. This provided a remarkable 
increase in solubilization capacity of DABCO surfactants aggregates (by ~4 times) [142]. Thus, 
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DABCO cationic surfactants are able of forming micellar aggregates in water with high solubilization 
capacity for hydrophobic dyes, drugs and organophosphorus toxicants. In these systems, the strategy 
can be realized for controlled binding/release of hydrophobic probes by means of the change in 
morphology of mixed aggregates and hence their affinity toward hydrophobic guests. They 
demonstrate advanced antimicrobial activity as compared to analogs with acyclic head groups. This 
anticipates that alkylated DABCO may be promising candidates for application in biotechnologies, 
which can be used for the development of nanocarriers with polyfunctional activity. 
6. Conclusions 
The survey of the recent publications strongly supports сationic amphiphiles as a very promising 
material in modern nano- and biotechnologies. The development of innovative functional 
nanocarriers based on cationic surfactants allows understanding the structure-activity correlation 
between chemical structure of the amphiphiles molecules and their aggregation behavior and 
functional activity (e.g., as drug delivery systems, catalysts, sensors). Noteworthy, the selection of 
papers for this review judged from the idea to reflect key trends in the field of bio- and 
nanotechnological applications of amphiphile-based systems, especially those positively charged. As 
can be seen, these trends focus on the development of drug delivery systems answering the criteria 
of green chemistry and biomimetic design. Therefore, the majority of strategies are aimed at the 
fabrication of soft and smart nanosized constructions, with the minimization of concentration of 
building blocks and their side effect attained. Moreover, it is still challenging to prepare nanocarriers 
with acceptable toxicological profile. In future studies, research towards the optimization of the 
formulations, and the study of structure-properties correlations are strongly needed, which brings to 
the forefront the systematic studies involving homological series of amphiphilic compounds and 
their directed functionalization. A steady trend that is assumed to be preserved consists in the use of 
gemini and polycationic compounds allowing for markedly diminish the usage of self-assemble units 
due to their low aggregation threshold. The same is true for the very promising compounds bearing 
cleavable moiety, e.g., ester and amide groups. Meanwhile, biomimetic approach assumes the wider 
use of natural components; therefore, amphiphiles bearing biofragments remain of special interest. 
Separate line in nanomedicine strategy involves the use of amphiphilic peptides and peptide-
conjugated formulations for delivery of both hydrophilic and hydrophobic therapeutic molecules. 
Noteworthy that preparation of drug delivery systems involving biological units may be 
administered through both covalent and non-covalent protocols. While the former provides more 
advantages in functional activity, the latter is less expensive and assumes the simpler and faster 
experiments. Therefore, the parity is probably expected to be preserved between these strategies. To 
sum up, one of the most relevant applications of cationic surfactants is the design of modified 
nanocontainers for drug and gene delivery. However, more in-depth studies need to be done, such 
as in vivo experiments to evaluate functional activity of the loaded cargos, due to the achievement of 
synergetic structural behavior and multidrug delivery with stimuli responsive activity. 
Author Contributions: All authors have substantially contributed for the conceptualization, methodology, 
formal analysis, investigation, resources, data curation, writing—original draft preparation, writing—review 
and editing, project administration, and funding acquisition. 
Funding: This research received funding from the Russian Science Foundation; grant No. 19-73-30012, and from 
the Portuguese Science and Technology Foundation (FCT) no. SFRH/BPD/101650/2014 granted to SD, 
SFRH/BD/130555/2017 granted to ARF, and project reference M-ERA-NET/0004/2015 (PAIRED). 
Conflicts of Interest: The authors declare no conflict of interest. 
References 
1. Shi, W.; He, S.; Wei, M.; Evans, D.G.; Duan, W. Optical pH Sensor with Rapid Response Based on a 
Fluorescein-Intercalated Layered Double Hydroxide. Adv. Funct. Mat. 2010, 20, 3856–3863, 
doi:10.1002/adfm.201001081. 
Int. J. Mol. Sci. 2019, 20, 5534 23 of 32 
2. Matile, S.; Vargas Jentzsch, A.; Montenegro, J.; Fin, A. Recent synthetic transport systems. Chem. Soc. Rev. 
2011, 40, 2453–2474, doi:10.1039/c0cs00209g. 
3. Busseron, E.; Ruff, Y.; Moulin, E.; Giuseppone, N. Supramolecular self-assemblies as functional 
nanomaterials. Nanoscale 2013, 5, 7098–7140, doi:10.1039/c3nr02176a. 
4. Zakharova, L.Y.; Pashirova, T.N.; Fernandes, A.R.; Doktorovova, S.; Martins-Gomes, C.; Silva, A.M.; Souto, 
E.B. Self-assembled quaternary ammonium surfactants for pharmaceuticals and biotechnology. In Organic 
Materials as Smart Nanocarriers for Drug Delivery, Grumezescu, A.M., Ed. William Andrew Publishing: 
Norwich, NY, USA, 2018; pp. 601–618. https://doi.org/10.1016/B978-0-12-813663-8.00014-2 
5. Paluch, E.; Piecuch, A.; Oblak, E.; Lamch, L.; Wilk, K.A. Antifungal activity of newly synthesized 
chemodegradable dicephalic-type cationic surfactants. Colloids Surf. B 2018, 164, 34–41, 
doi:10.1016/j.colsurfb.2018.01.020. 
6. Wang, L.; Zhao, Q.; Zhang, Z.; Lu, Z.; Zhao, Y.; Tang, Y. Fluorescent Conjugated Polymer/Quarternary 
Ammonium Salt Co-assembly Nanoparticles: Applications in Highly Effective Antibacteria and 
Bioimaging. Acs Appl. Bio. Mater. 2018, 1, 1478–1486, doi:10.1021/acsabm.8b00422. 
7. Shalabi, K.; Helmy, A.M.; El-Askalany, A.H.; Shahba, M.M. New pyridinium bromide mono-cationic 
surfactant as corrosion inhibitor for carbon steel during chemical cleaning: Experimental and theoretical 
studies. J. Mol. Liq. 2019, 293, 111480, doi:https://doi.org/10.1016/j.molliq.2019.111480. 
8. Buurma, N.J. Aggregation and reactivity in aqueous solutions of cationic surfactants and aromatic anions 
across concentration scales. Curr. Opin. Colloid Interface Sci. 2017, 32, 69–75, 
doi:https://doi.org/10.1016/j.cocis.2017.10.005. 
9. Wang, L.; Quan, P.; Chen, S.H.; Bu, W.; Li, Y.-F.; Wu, X.; Wu, J.; Zhang, L.; Zhao, Y.; Jiang, X.; et al. Stability 
of Ligands on Nanoparticles Regulating the Integrity of Biological Membranes at the Nano–Lipid Interface. 
ACS Nano 2019, 13, 8680–8693, doi:10.1021/acsnano.9b00114. 
10. Botto, C.; Mauro, N.; Amore, E.; Martorana, E.; Giammona, G.; Bondi, M.L. Surfactant effect on the 
physicochemical characteristics of cationic solid lipid nanoparticles. Int. J. Pharm. 2017, 516, 334–341, 
doi:10.1016/j.ijpharm.2016.11.052. 
11. Muzzalupo, R.; Perez, L.; Pinazo, A.; Tavano, L. Pharmaceutical versatility of cationic niosomes derived 
from amino acid-based surfactants: Skin penetration behavior and controlled drug release. Int. J. Pharm. 
2017, 529, 245–252, doi:10.1016/j.ijpharm.2017.06.083. 
12. Lopez-Lopez, M.; Lopez-Cornejo, P.; Martin, V.I.; Ostos, F.J.; Checa-Rodriguez, C.; Prados-Carvajal, R.; 
Lebron, J.A.; Huertas, P.; Moya, M.L. Importance of hydrophobic interactions in the single-chained cationic 
surfactant-DNA complexation. J. Colloid Interface Sci. 2018, 521, 197–205, doi:10.1016/j.jcis.2018.03.048. 
13. Guo, Q.; Zhang, Z.; Song, Y.; Liu, S.; Gao, W.; Qiao, H.; Guo, L.; Wang, J. Investigation on interaction of 
DNA and several cationic surfactants with different head groups by spectroscopy, gel electrophoresis and 
viscosity technologies. Chemosphere 2017, 168, 599–605, 
doi:https://doi.org/10.1016/j.chemosphere.2016.11.019. 
14. Edeas, M.; Weissig, V. Targeting mitochondria: Strategies, innovations and challenges: The future of 
medicine will come through mitochondria. Mitochondrion 2013, 13, 389–390, 
doi:https://doi.org/10.1016/j.mito.2013.03.009. 
15. Kalyanaraman, B.; Cheng, G.; Hardy, M.; Ouari, O.; Lopez, M.; Joseph, J.; Zielonka, J.; Dwinell, M.B. A 
review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer 
cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds. Redox Biol. 2018, 
14, 316–327, doi:https://doi.org/10.1016/j.redox.2017.09.020. 
16. Garcia, M.T.; Ribosa, I.; Kowalczyk, I.; Pakiet, M.; Brycki, B. Biodegradability and aquatic toxicity of new 
cleavable betainate cationic oligomeric surfactants. J. Hazard. Mater. 2019, 371, 108–114, 
doi:https://doi.org/10.1016/j.jhazmat.2019.03.005. 
17. Shahzadi, I.; Asim, M.H.; Dizdarević, A.; Wolf, J.D.; Kurpiers, M.; Matuszczak, B.; Bernkop-Schnürch, A. 
Arginine-based cationic surfactants: Biodegradable auxiliary agents for the formation of hydrophobic ion 
pairs with hydrophilic macromolecular drugs. J. Colloid Interface Sci. 2019, 552, 287–294, 
doi:https://doi.org/10.1016/j.jcis.2019.05.057. 
18. Wang, Y.; Jiang, Y.; Geng, T.; Ju, H.; Duan, S. Synthesis, surface/interfacial properties, and biological activity 
of amide-based Gemini cationic surfactants with hydroxyl in the spacer group. Colloids Surf. A 2019, 563, 
1–10, doi:https://doi.org/10.1016/j.colsurfa.2018.11.061. 
Int. J. Mol. Sci. 2019, 20, 5534 24 of 32 
19. Felgner, P.L.; Gadek, T.R.; Holm, M.; Roman, R.; Chan, H.W.; Wenz, M.; Northrop, J.P.; Ringold, G.M.; 
Danielsen, M. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. 
Sci. USA 1987, 84, 7413–7417, doi:10.1073/pnas.84.21.7413. 
20. Campbell, R.B.; Ying, B.; Kuesters, G.M.; Hemphill, R. Fighting Cancer: From the Bench to Bedside Using 
Second Generation Cationic Liposomal Therapeutics. J. Pharm. Sci. 2009, 98, 411–429, doi:10.1002/jps.21458. 
21. G., S. EndoTAG-1. MediGene. Curr. Opin. Investig. Drugs 2005, 6, 1259–1265. 
22. Ignatiadis, M.; Zardavas, D.; Lemort, M.; Wilke, C.; Vanderbeeken, M.-C.; D’Hondt, V.; De Azambuja, E.; 
Gombos, A.; Lebrun, F.; Dal Lago, L., et al. Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting 
Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast 
Cancer. PLoS ONE 2016, 11, e0154009-e0154009, doi:10.1371/journal.pone.0154009. 
23. Souza, J.G.; Dias, K.; Pereira, T.A.; Bernardi, D.S.; Lopez, R.F. Topical delivery of ocular therapeutics: 
Carrier systems and physical methods. J. Pharm. Pharm. 2014, 66, 507–530, doi:10.1111/jphp.12132. 
24. Fangueiro, J.F.; Silva, A.M.; Garcia, M.L.; Souto, E.B. Current nanotechnology approaches for the treatment 
and management of diabetic retinopathy. Eur J. Pharm. Biopharm. 2014, 95, 307-322. 
25. Fangueiro, J.F.; Andreani, T.; Egea, M.A.; Garcia, M.L.; Souto, S.B.; Silva, A.M.; Souto, E.B. Design of 
cationic lipid nanoparticles for ocular delivery: Development, characterization and cytotoxicity. Int. J. 
Pharm. 2014, 461, 64–73, doi:10.1016/j.ijpharm.2013.11.025. 
26. Mirgorodskaya, A.B.; Kushnazarova, R.A.; Lukashenko, S.S.; Zakharova, L.Y. Self-assembly of mixed 
systems based on nonionic and carbamate-bearing cationic surfactants as a tool for fabrication of 
biocompatible nanocontainers. J. Mol. Liq. 2019, 292, 111407, 
doi:https://doi.org/10.1016/j.molliq.2019.111407. 
27. Dhawan, V.V.; Nagarsenker, M.S. Catanionic systems in nanotherapeutics – Biophysical aspects and novel 
trends in drug delivery applications. J. Control. Release 2017, 266, 331–345, 
doi:https://doi.org/10.1016/j.jconrel.2017.09.040. 
28. Buck, J.; Grossen, P.; Cullis, P.R.; Huwyler, J.; Witzigmann, D. Lipid-Based DNA Therapeutics: Hallmarks 
of Non-Viral Gene Delivery. ACS Nano 2019, 13, 3754–3782, doi:10.1021/acsnano.8b07858. 
29. Zhi, D.; Bai, Y.; Yang, J.; Cui, S.; Zhao, Y.; Chen, H.; Zhang, S. A review on cationic lipids with different 
linkers for gene delivery. Adv. Colloid Interface Sci. 2018, 253, 117–140, 
doi:https://doi.org/10.1016/j.cis.2017.12.006. 
30. Grijalvo, S.; Puras, G.; Zárate, J.; Sainz-Ramos, M.; Qtaish, N.A.L.; López, T.; Mashal, M.; Attia, N.; Díaz, 
D.; Pons, R., et al. Cationic Niosomes as Non-Viral Vehicles for Nucleic Acids: Challenges and 
Opportunities in Gene Delivery. Pharmaceutics 2019, 11, 50, doi:10.3390/pharmaceutics11020050. 
31. Damen, M.; Groenen, A.J.J.; van Dongen, S.F.M.; Nolte, R.J.M.; Scholte, B.J.; Feiters, M.C. Transfection by 
cationic gemini lipids and surfactants. Med. Chem. Comm. 2018, 9, 1404–1425, doi:10.1039/C8MD00249E. 
32. Silva, L.L.; Zapelini, I.W.; Cardoso, D. Catalytic transesterification by hybrid silicas containing CnTA+ 
surfactants. Catal. Today 2019. doi: //doi.org/10.1016/j.cattod.2019.07.030.  
33. Obłąk, E.; Piecuch, A.; Rewak-Soroczyńska, J.; Paluch, E.J.A.M. Biotechnology. Activity of gemini 
quaternary ammonium salts against microorganisms. Appl. Microbiol. Biotechnol., 103, 625–632, 
doi:10.1007/s00253-018-9523-2. 
34. Fait, M.E.; Bakas, L.; Garrote, G.L.; Morcelle, S.R.; Saparrat, M.C.N.J.A.M. Biotechnology. Cationic 
surfactants as antifungal agents. Appl. Microbiol. Biotechnol. 2019, 103, 97–112, doi:10.1007/s00253-018-9467-
6. 
35. Le Guenic, S.; Chaveriat, L.; Lequart, V.; Joly, N.; Martin, P. Renewable Surfactants for Biochemical 
Applications and Nanotechnology. J. Surfactants Deterg. 2019, 22, 5–21, doi:10.1002/jsde.12216. 
36. Kapitanov, I.V.; Jordan, A.; Karpichev, Y.; Spulak, M.; Perez, L.; Kellett, A.; Kümmerer, K.; Gathergood, N. 
Synthesis, self-assembly, bacterial and fungal toxicity, and preliminary biodegradation studies of a series 
of l-phenylalanine-derived surface-active ionic liquids. Green Chem. 2019, 21, 1777–1794, 
doi:10.1039/C9GC00030E. 
37. Hoque, J.; Akkapeddi, P.; Yarlagadda, V.; Uppu, D.S.S.M.; Kumar, P.; Haldar, J. Cleavable Cationic 
Antibacterial Amphiphiles: Synthesis, Mechanism of Action, and Cytotoxicities. Langmuir 2012, 28, 12225–
12234, doi:10.1021/la302303d. 
38. Menger, F.M.; Keiper, J.S. Gemini Surfactants. Angew. Chem. Int. Ed. 2000, 39, 1906–1920, doi:10.1002/1521-
3773(20000602)39:11<1906::Aid-anie1906>3.0.Co;2-q. 
Int. J. Mol. Sci. 2019, 20, 5534 25 of 32 
39. Kirby, A.J.; Camilleri, P.; Engberts, J.B.F.N.; Feiters, M.C.; Nolte, R.J.M.; Söderman, O.; Bergsma, M.; Bell, 
P.C.; Fielden, M.L.; García Rodríguez, C.L.; et al. Gemini Surfactants: New Synthetic Vectors for Gene 
Transfection. Angew. Chem. Int. Ed. 2003, 42, 1448–1457, doi:10.1002/anie.200201597. 
40. Castro, M.; Griffiths, D.; Patel, A.; Pattrick, N.; Kitson, C.; Ladlow, M. Effect of chain length on transfection 
properties of spermine-based gemini surfactants. Org. Biomol. Chem. 2004, 2, 2814–2820, 
doi:10.1039/B410240A. 
41. Colomer, A.; Pinazo, A.; Manresa, M.A.; Vinardell, M.P.; Mitjans, M.; Infante, M.R.; Pérez, L. Cationic 
Surfactants Derived from Lysine: Effects of Their Structure and Charge Type on Antimicrobial and 
Hemolytic Activities. J. Med. Chem. 2011, 54, 989–1002, doi:10.1021/jm101315k. 
42. Al-Dulaymi, M.; Mohammed-Saeid, W.; El-Aneed, A.; Badea, I. Peptide-Modified Gemini Surfactants: 
Preparation and Characterization for Gene Delivery. Methods Mol. Biol. 2019, 2000, 203–225, 
doi:10.1007/978-1-4939-9516-5_14. 
43. Pisárčik, M.; Polakovičová, M.; Markuliak, M.; Lukáč, M.; Devínsky, F. Self-Assembly Properties of Cationic 
Gemini Surfactants with Biodegradable Groups in the Spacer. Molecules 2019, 24, 1481. 
44. Datta, S.; Biswas, J.; Bhattacharya, S. How does spacer length of imidazolium gemini surfactants control 
the fabrication of 2D-Langmuir films of silver-nanoparticles at the air-water interface? J. Colloid Interface 
Sci. 2014, 430, 85–92, doi:10.1016/j.jcis.2014.05.018S0021-9797(14)00309-9 [pii]. 
45. Adak, S.; Datta, S.; Bhattacharya, S.; Banerjee, R. Role of spacer length in interaction between novel gemini 
imidazolium surfactants and Rhizopus oryzae lipase. Int. J. Biol. Macromol. 2015, 81, 560–567, 
doi:10.1016/j.ijbiomac.2015.08.051. 
46. Garcia, J.P.; Marron, E.; Martin, V.I.; Moya, M.L.; Lopez-Cornejo, P. Conformational changes of DNA in the 
presence of 12-s-12 gemini surfactants (s = 2 and 10). Role of the spacer’s length in the interaction surfactant-
polynucleotide. Colloids Surf. B 2014, 118, 90–100, doi:10.1016/j.colsurfb.2014.03.040. 
47. Alama, T.; Kusamori, K.; Morishita, M. Mechanistic Studies on the Absorption-Enhancing Effects of Gemini 
Surfactant on the Intestinal Absorption of Poorly Absorbed Hydrophilic Drugs in Rats. Pharmaceutics 2019, 
11, doi:10.3390/pharmaceutics11040170. 
48. Cardoso, A.M.; Morais, C.M.; Cruz, A.R.; Silva, S.G.; do Vale, M.L.; Marques, E.F.; de Lima, M.C.; Jurado, 
A.S. New serine-derived gemini surfactants as gene delivery systems. Eur. J. Pharm. Biopharm. 2015, 89, 347–
356, doi:10.1016/j.ejpb.2014.12.013. 
49. Emara, M.M.; Abdel-Salam, F.H.; Ali, R.A.; Turky, A.S.; Elghayish, M.M. Synthesis and Evaluation of 
Surface Activity of Gemini Borate Surfactants Based on Glucose Moiety. J. Dispers. Sci. Technol. 2016, 37, 
733–742, doi:10.1080/01932691.2015.1060487. 
50. Mirgorodskaya, A.B.; Kudryavtseva, L.A.; Pankratov, V.A.; Lukashenko, S.S.; Rizvanova, L.Z.; Konovalov, 
A.I. Geminal alkylammonium surfactants: Aggregation properties and catalytic activity. Russ. J. Gen. Chem. 
2006, 76, 1625–1631, doi:10.1134/s1070363206100215. 
51. Zana, R. Dimeric (gemini) surfactants: Effect of the spacer group on the association behavior in aqueous 
solution. J. Colloid Interface Sci. 2002, 248, 203–220, doi:S0021-9797(01)98104-4 [pii] 10.1006/jcis.2001.8104. 
52. Mirgorodskaya, A.B.; Yackevich, E.I.; Lukashenko, S.S.; Zakharova, L.Y.; Konovalov, A.I. Solubilization 
and catalytic behavior of micellar system based on gemini surfactant with hydroxyalkylated head group. 
J. Mol. Liq. 2012, 169, 106–109, doi:http://dx.doi.org/10.1016/j.molliq.2012.02.012. 
53. Łuczyński, J.; Frąckowiak, R.; Włoch, A.; Kleszczyńska, H.; Witek, S. Gemini ester quat surfactants and 
their biological activity. Cell. Mol. Biol. Lett. 2013, 18, 89–101. 
54. Tehrani-Bagha, A.R.; Holmberg, K.; van Ginkel, C.G.; Kean, M. Cationic gemini surfactants with cleavable 
spacer: Chemical hydrolysis, biodegradation, and toxicity. J. Colloid Interface Sci. 2015, 449, 72–79, 
doi:10.1016/j.jcis.2014.09.072. 
55. Casal-Dujat, L.; Griffiths, P.C.; Rodríguez-Abreu, C.; Solans, C.; Rogers, S.; Pérez-García, L. Nanocarriers 
from dicationic bis-imidazolium amphiphiles and their interaction with anionic drugs. J. Mater. Chem. B 
2013, 1, 4963–4971. 
56. Zhang, X.; Peng, X.; Ge, L.; Yu, L.; Liu, Z.; R., G. Micellization behavior of the ionic liquid lauryl 
isoquinolinium bromide in aqueous solution. Colloid Polym. Sci. 2014, 292, 1111–1120. 
57. Ping, A.; Geng, P.; Zhang, J.; Liu, J.; Sun, D.; Zhang, X.; Li, Q.; Liu, J.; Wei, X. Rheological Behavior of 
Aqueous Solutions of An Ionic Liquid As A Surfactant. Soft Matter 2014, 12, 326–333. 
Int. J. Mol. Sci. 2019, 20, 5534 26 of 32 
58. Tourne-Peteilh, C.; Coasne, B.; In, M.; Brevet, D.; Devoisselle, J.M.; Vioux, A.; Viau, L. Surfactant behavior 
of ionic liquids involving a drug: From molecular interactions to self-assembly. Langmuir 2014, 30, 1229–
1238, doi:10.1021/la404166y. 
59. Jiao, J.; Han, B.; Lin, M.; Cheng, N.; Yu, L.; Liu, M. Salt-free catanionic surface active ionic liquids 1-alkyl-
3-methylimidazolium alkylsulfate: Aggregation behavior in aqueous solution. J. Colloid Interface Sci. 2013, 
412, 24–30, doi:10.1016/j.jcis.2013.09.001S0021-9797(13)00814-X [pii]. 
60. Wang, H.; Zhang, L.; Wang, J.; Li, Z.; Zhang, S. The first evidence for unilamellar vesicle formation of ionic 
liquids in aqueous solutions. Chem. Commun. 2013, 49, 5222–5224, doi:10.1039/c3cc41908h. 
61. Mester, P.; Wagner, M.; Rossmanith, P. Antimicrobial effects of short chained imidazolium-based ionic 
liquids-influence of anion chaotropicity. Ecotoxicol. Env. Saf. 2015, 111, 96–101, 
doi:10.1016/j.ecoenv.2014.08.032S0147-6513(14)00410-2 [pii]. 
62. Rodrigues, M.; Calpena, A.C.; Amabilino, D.B.; Ramos-López, D.; Lapuentee, J.; Pérez-García, L. Water-
soluble gold nanoparticles based on imidazolium gemini amphiphiles incorporating piroxicam. RSC. Adv. 
2014, 4, 9279–9287. 
63. Doktorovova, S.; Silva, A.M.; Gaivao, I.; Souto, E.B.; Teixeira, J.P.; Martins-Lopes, P. Comet assay reveals 
no genotoxicity risk of cationic solid lipid nanoparticles. J. Appl. Toxicol. 2014, 34, 395–403, 
doi:10.1002/jat.2961. 
64. Semenov, V. Chemistry of pyrimidinophanes: Synthesis and applications: A review from 1990 until 
recently. J. Incl. Phenom. Macrocycl. Chem. 2013, 77, 1–22, doi:10.1007/s10847-012-0274-x. 
65. Kharlamov, S.V.; Voronin, M.A.; Semenov, V.E.; Gabdrakhmanov, D.R.; Strobykina, A.S.; Nikolaev, A.E.; 
Reznik, V.S.; Zakharova, L.Y.; Konovalov, A.I. Tunable biomimetic systems based on a novel amphiphilic 
pyrimidinophane and a helper nonionic surfactant. Colloids Surf. B 2013, 111, 218–223, 
doi:10.1016/j.colsurfb.2013.06.006S0927-7765(13)00372-X [pii]. 
66. Zakharova, L.; Syakaev, V.; Voronin, M.; Semenov, V.; Valeeva, F.; Ibragimova, A.; Bilalov, A.; Giniyatullin, 
R.; Latypov, S.; Reznik, V., et al. New self-assembling systems based on bola-type pyrimidinic surfactants. 
J. Colloid Interface Sci. 2010, 342, 119–127, doi:10.1016/j.jcis.2009.10.006S0021-9797(09)01319-8 [pii]. 
67. Zakharova, L.Y.; Semenov, V.E.; Syakaev, V.V.; Voronin, M.A.; Gabdrakhmanov, D.R.; Valeeva, F.G.; 
Mikhailov, A.S.; Voloshina, A.D.; Reznik, V.S.; Latypov, S.K., et al. Amphiphilic macrocycles bearing 
biofragment: Molecular design as factor controlling self-assembly. Mater. Biol. Appl. 2014, 38, 143–150. 
68. Voronin, M.A.; Gabdrakhmanov, D.R.; Semenov, V.E.; Valeeva, F.G.; Mikhailov, A.S.; Nizameev, I.R.; 
Kadirov, M.K.; Zakharova, L.Y.; Reznik, V.S.; Konovalov, A.I. Novel bolaamphiphilic pyrimidinophane as 
building block for design of nanosized supramolecular systems with concentration-dependent structural 
behavior. Acs Appl. Mater. Interfaces 2011, 3, 402–409. 
69. Gabdrakhmanov, D.R.; Valeeva, F.G.; Nikolaev, A.E.; Giniyatullin, R.K.; Semenov, V.E.; Reznik, V.S.; 
Zakharova, L.Y. Self-organization of oligomeric amphiphiles with pyrimidine moieties: The role of the 
structural factor. J. Struct. Chem. 2014, 55, 1548–1555, doi:10.1134/s0022476614080241. 
70. Tavano, L.; Pinazo, A.; Abo-Riya, M.; Infante, M.R.; Manresa, M.A.; Muzzalupo, R.; Pérez, L. Cationic 
vesicles based on biocompatible diacyl glycerol-arginine surfactants: Physicochemical properties, 
antimicrobial activity, encapsulation efficiency and drug release. Colloids Surf. B 2014, 120, 160–167, 
doi:http://dx.doi.org/10.1016/j.colsurfb.2014.04.009. 
71. Perez, L.; Pinazo, A.; Teresa Garcia, M.; Lozano, M.; Manresa, A.; Angelet, M.; Pilar Vinardell, M.; Mitjans, 
M.; Pons, R.; Rosa Infante, M. Cationic surfactants from lysine: Synthesis, micellization and biological 
evaluation. Eur. J. Med. Chem. 2009, 44, 1884–1892, doi:10.1016/j.ejmech.2008.11.003. 
72. Tavano, L.; Infante, M.R.; Abo Riya, M.; Pinazo, A.; Vinardell, M.P.; Mitjans, M.; Manresa, M.A.; Perez, L. 
Role of aggregate size in the hemolytic and antimicrobial activity of colloidal solutions based on single and 
gemini surfactants from arginine. Soft Matter 2013, 9, 306–319. 
73. Teixeira, R.S.; Cova, T.F.; Silva, S.M.; Oliveira, R.; do Vale, M.L.; Marques, E.F.; Pais, A.A.; Veiga, F.J. Novel 
serine-based gemini surfactants as chemical permeation enhancers of local anesthetics: A comprehensive 
study on structure-activity relationships, molecular dynamics and dermal delivery. Eur. J. Pharm. Biopharm. 
2015, 93, 205–213, doi:10.1016/j.ejpb.2015.02.024. 
74. Bordes, R.; Holmberg, K. Amino acid-based surfactants - do they deserve more attention? Adv. Colloid 
Interface Sci. 2015, 222, 79–91, doi:10.1016/j.cis.2014.10.013. 
75. Nogueira, D.R.; del Carmen Moran, M.; Mitjans, M.; Perez, L.; Ramos, D.; de Lapuente, J.; Pilar Vinardell, 
M. Lysine-based surfactants in nanovesicle formulations: The role of cationic charge position and 
Int. J. Mol. Sci. 2019, 20, 5534 27 of 32 
hydrophobicity in in vitro cytotoxicity and intracellular delivery. Nanotoxicology 2014, 8, 404–421, 
doi:10.3109/17435390.2013.793779. 
76. Nogueira, D.R.; Moran, M.C.; Mitjans, M.; Martinez, V.; Perez, L.; Vinardell, M.P. New cationic 
nanovesicular systems containing lysine-based surfactants for topical administration: Toxicity assessment 
using representative skin cell lines. Eur. J. Pharm. Biopharm. 2013, 83, 33–43, 
doi:10.1016/j.ejpb.2012.09.007S0939-6411(12)00291-3 [pii]. 
77. Calejo, M.T.; Cardoso, A.M.; Marques, E.F.; Araujo, M.J.; Kjoniksen, A.L.; Sande, S.A.; de Lima, M.C.; 
Jurado, A.S.; Nystrom, B. In vitro cytotoxicity of a thermoresponsive gel system combining 
ethyl(hydroxyethyl) cellulose and lysine-based surfactants. Colloids Surf. B 2013, 102, 682–686, 
doi:10.1016/j.colsurfb.2012.09.033. 
78. Teixeira, R.S.; Cova, T.F.; Silva, S.M.; Oliveira, R.; Araujo, M.J.; Marques, E.F.; Pais, A.A.; Veiga, F.J. Lysine-
based surfactants as chemical permeation enhancers for dermal delivery of local anesthetics. Int. J. Pharm. 
2014, 474, 212–222, doi:10.1016/j.ijpharm.2014.08.002. 
79. Akong, F.O.; Pasc, A.; Emo, M.; Gérardin-Charbonnier, C. A supramolecular hydrogel based on an original 
pseudopeptidic catanionic surfactant. New J. Chem. 2013, 37, 559–562. 
80. Gabdrakhmanov, D.R.; Voronin, M.A.; Zakharova, L.Y.; Konovalov, A.I.; Khaybullin, R.N.; Strobykina, 
I.Y.; Kataev, V.E.; Faizullin, D.A.; Gogoleva, N.E.; Konnova, T.A.; et al. Supramolecular design of 
biocompatible nanocontainers based on amphiphilic derivatives of a natural compound isosteviol. Phys. 
Chem. Chem. Phys. 2013, 15, 16725–16735, doi:10.1039/c3cp51511g. 
81. Sharma, R.; Kamal, A.; Abdinejad, M.; Mahajan, R.K.; Kraatz, H.-B. Advances in the synthesis, molecular 
architectures and potential applications of gemini surfactants. Adv. Colloid Interface Sci. 2017, 248, 35–68, 
doi:https://doi.org/10.1016/j.cis.2017.07.032. 
82. Gonçalves Lopes, R.C.F.; Silvestre, O.F.; Faria, A.R.; C. do Vale, M.L.; Marques, E.F.; Nieder, J.B. Surface 
charge tunable catanionic vesicles based on serine-derived surfactants as efficient nanocarriers for the 
delivery of the anticancer drug doxorubicin. Nanoscale 2019, 11, 5932–5941, doi:10.1039/C8NR06346J. 
83. Kumar, A.; Chen, F.; Mozhi, A.; Zhang, X.; Zhao, Y.; Xue, X.; Hao, Y.; Wang, P.C.; Liang, X.J. Innovative 
pharmaceutical development based on unique properties of nanoscale delivery formulation. Nanoscale 
2013, 5, 8307–8325, doi:10.1039/c3nr01525d. 
84. Mu, H.; Holm, R.; Mullertz, A. Lipid-based formulations for oral administration of poorly water-soluble 
drugs. Int. J. Pharm. 2013, 453, 215–224, doi:10.1016/j.ijpharm.2013.03.054S0378-5173(13)00284-6 [pii]. 
85. Lépori, C.M.O.; Correa, N.M.; Silber, J.J.; Falcone, R.D.; López-López, M.; Moyá, M.L. Use of Ionic Liquids-
like Surfactants for the Generation of Unilamellar Vesicles with Potential Applications in Biomedicine. 
Langmuir 2019. doi:10.1021/acs.langmuir.9b01197. 
86. Teixeira, H.F.; Bruxel, F.; Fraga, M.; Schuh, R.S.; Zorzi, G.K.; Matte, U.; Fattal, E. Cationic nanoemulsions 
as nucleic acids delivery systems. Int. J. Pharm. 2017, 534, 356–367, 
doi:https://doi.org/10.1016/j.ijpharm.2017.10.030. 
87. Shaban, S.M.; Abd-Elaal, A.A. Studying the silver nanoparticles influence on thermodynamic behavior and 
antimicrobial activities of novel amide Gemini cationic surfactants. Mater. Sci. Eng. 2017, 76, 871–885, 
doi:https://doi.org/10.1016/j.msec.2017.03.185. 
88. Fameau, A.L.; Zemb, T. Self-assembly of fatty acids in the presence of amines and cationic components. 
Adv. Colloid Interface Sci. 2014, 207, 43–64, doi:10.1016/j.cis.2013.11.017S0001-8686(13)00170-X [pii]. 
89. Oh, H.; Lu, A.X.; Javvaji, V.; DeVoe, D.L.; Raghavan, S.R. Light-Directed Self-Assembly of Robust Alginate 
Gels at Precise Locations in Microfluidic Channels. Acs Appl. Mater. Interfaces 2016, 8, 17529–17538, 
doi:10.1021/acsami.6b03826. 
90. Yang, D.; Zhao, J. A light-responsive organofluid based on reverse worm-like micelles formed from an 
equi-charged, mixed, anionic gemini surfactant with an azobenzene spacer and a cationic conventional 
surfactant. Soft Matter 2016, 12, 4044–4051, doi:10.1039/C6SM00207B. 
91. Pucci, C.; Perez, L.; La Mesa, C.; Pons, R. Characterization and stability of catanionic vesicles formed by 
pseudo-tetraalkyl surfactant mixtures. Soft Matter 2014, 10, 9657–9667, doi:10.1039/c4sm01575d. 
92. Wang, D.; Ou, K.; Yang, Z.; Lin, M.; Dong, Z. Thermodynamic insights and molecular environments into 
catanionic surfactant systems: Influence of chain length and molar ratio. J. Colloid Interface Sci. 2019, 548, 
77–87, doi:https://doi.org/10.1016/j.jcis.2019.04.023. 
93. Tah, B.; Pal, P.; Talapatra, G.B. Interaction of insulin with SDS/CTAB catanionic vesicles. J. Lumin. 2014, 
145, 81–87. 
Int. J. Mol. Sci. 2019, 20, 5534 28 of 32 
94. Castagnos, P.; Siqueira-Moura, M.P.; Leme Goto, P.; Perez, E.; Franceschi, S.; Rico-Lattes , I.; Tedesco, A.C.; 
Blanzat, M. Catanionic vesicles charged with chloroaluminium phthalocyanine for topical photodynamic 
therapy. In vitro phototoxicity towards human carcinoma and melanoma cell lines. Rsc Adv. 2014, 4, 39372–
39377. 
95. Oh, H.; Javvaji, V.; Yaraghi, N.A.; Abezgauz, L.; Danino, D.; Raghavan, S.R. Light-induced transformation 
of vesicles to micelles and vesicle-gels to sols. Soft Matter 2013, 9, 11576–11584. 
96. Ojeda, E.; Puras, G.; Agirre, M.; Zarate, J.; Grijalvo, S.; Eritja, R.; Martinez-Navarrete, G.; Soto-Sánchez, C.; 
Diaz-Tahoces, A.; Aviles-Trigueros, M., et al. The influence of the polar head-group of synthetic cationic 
lipids on the transfection efficiency mediated by niosomes in rat retina and brain. Biomaterials 2016, 77, 267–
279, doi:https://doi.org/10.1016/j.biomaterials.2015.11.017. 
97. Li, W.; Shi, J.; Zhang, C.; Li, M.; Gan, L.; Xu, H.; Yang, X. Co-delivery of thioredoxin 1 shRNA and 
doxorubicin by folate-targeted gemini surfactant-based cationic liposomes to sensitize hepatocellular 
carcinoma cells. J. Mater. Chem. B 2014, 2, 4901, doi:10.1039/c4tb00502c. 
98. Saengkrit, N.; Saesoo, S.; Srinuanchai, W.; Phunpee, S.; Ruktanonchai, U.R. Influence of curcumin-loaded 
cationic liposome on anticancer activity for cervical cancer therapy. Colloids Surf. B 2014, 114, 349–356, 
doi:10.1016/j.colsurfb.2013.10.005S0927-7765(13)00630-9 [pii]. 
99. Duangjit, S.; Pamornpathomkul, B.; Opanasopit, P.; Rojanarata, T.; Obata, Y.; Takayama, K.; 
Ngawhirunpat, T. Role of the charge, carbon chain length, and content of surfactant on the skin penetration 
of meloxicam-loaded liposomes. Int. J. Nanomed. 2014, 9, 2005–2017, doi:10.2147/IJN.S60674ijn-9-2005 [pii]. 
100. Pinazo, A.; Petrizelli, V.; Bustelo, M.; Pons, R.; Vinardell, M.P.; Mitjans, M.; Manresa, A.; Perez, L. New 
cationic vesicles prepared with double chain surfactants from arginine: Role of the hydrophobic group on 
the antimicrobial activity and cytotoxicity. Colloids Surf. B 2016, 141, 19–27, 
doi:https://doi.org/10.1016/j.colsurfb.2016.01.020. 
101. Bazylińska, U.; Zieliński, W.; Kulbacka, J.; Samoć, M.; Wilk, K.A. New diamidequat-type surfactants in 
fabrication of long-sustained theranostic nanocapsules: Colloidal stability, drug delivery and bioimaging. 
Colloids Surf. B 2016, 137, 121–132, doi:https://doi.org/10.1016/j.colsurfb.2015.06.043. 
102. Malik, P.; Singh, M. Study of curcumin antioxidant activities in robust oil–water nanoemulsions. New J. 
Chem. 2017, 41, 12506–12519, doi:10.1039/C7NJ02612A. 
103. Kamimura, M.; Kim, J.O.; Kabanov, A.V.; Bronich, T.K.; Nagasaki, Y. Block ionomer complexes of PEG-
block-poly(4-vinylbenzylphosphonate) and cationic surfactants as highly stable, pH responsive drug 
delivery system. J. Control. Release 2012, 160, 486–494, doi:10.1016/j.jconrel.2012.04.027. 
104. Bengani, L.C.; Chauhan, A. Extended delivery of an anionic drug by contact lens loaded with a cationic 
surfactant. Biomaterials 2013, 34, 2814–2821, doi:10.1016/j.biomaterials.2012.12.027S0142-9612(12)01407-X 
[pii]. 
105. Doktorovova, S.; Santos, D.L.; Costa, I.; Andreani, T.; Souto, E.B.; Silva, A.M. Cationic solid lipid 
nanoparticles interfere with the activity of antioxidant enzymes in hepatocellular carcinoma cells. Int. J. 
Pharm. 2014, 471, 18–27, doi:10.1016/j.ijpharm.2014.05.011. 
106. Pisárčik, M.; Lukáč, M.; Jampílek, J.; Bilka, F.; Bilková, A.; Pašková, Ľ.; Devínsky, F.; Horáková, R.; Opravil, 
T. Silver nanoparticles stabilised with cationic single-chain surfactants. Structure-physical properties-
biological activity relationship study. J. Mol. Liq. 2018, 272, 60–72, 
doi:https://doi.org/10.1016/j.molliq.2018.09.042. 
107. Alea-Reyes, M.E.; González, A.; Calpena, A.C.; Ramos-López, D.; de Lapuente, J.; Pérez-García, L. Gemini 
pyridinium amphiphiles for the synthesis and stabilization of gold nanoparticles for drug delivery. J. 
Colloid Interface Sci. 2017, 502, 172–183, doi:https://doi.org/10.1016/j.jcis.2017.04.064. 
108. Andreani, T.; Kiill, C.P.; Souza, A.L.R.d.; Fangueiro, J.F.; Fernandes, L.; Doktorovová, S.; Santos, D.L.; 
Garcia, M.L.; Gremião, M.P.D.; Souto, E.B., et al. Surface engineering of silica nanoparticles for oral insulin 
delivery: Characterization and cell toxicity studies. Colloids Surf. B 2014, 123, 916–923, 
doi:http://dx.doi.org/10.1016/j.colsurfb.2014.10.047. 
109. Andreani, T.; Silva, A.M.; Souto, E.B. Silica-based matrices: State of the art and new perspectives for 
therapeutic drug delivery. Biotechnol. Appl. Biochem. 2015, doi: 10.1002/bab.1322, n/a-n/a. 
110. Cesaretti, A.; Carlotti, B.; Gentili, P.L.; Clementi, C.; Germani, R.; Elisei, F. Spectroscopic investigation of 
the pH controlled inclusion of doxycycline and oxytetracycline antibiotics in cationic micelles and their 
magnesium driven release. J. Phys. Chem. B 2014, 118, 8601–8613. 
Int. J. Mol. Sci. 2019, 20, 5534 29 of 32 
111. Tehrani-Bagha, A.R.; Holmberg, K. Solubilization of hydrophobic dyes in surfactant solutions. Materials 
2013, 6, 580–608. 
112. Mahajan, S.; Sharma, R.; Mahajan, R.K. An investigation of drug binding ability of a surface active ionic 
liquid: Micellization, electrochemical, and spectroscopic studies. Langmuir 2012, 28, 17238–17246, 
doi:10.1021/la303193n. 
113. Masrat, R.; Maswal, M.; Dar, A.A. Competitive solubilization of naphthalene and pyrene in various micellar 
systems. J. Hazard. Mater. 2013, 244-245, 662-670. 
114. Singh, S.; Bhadoria, A.; Parikh, K.; Yadav, S.K.; Kumar, S.; Aswal, V.K.; Kumar, S. Self-Assembly in 
Aqueous Oppositely Charged Gemini Surfactants: A Correlation between Morphology and Solubilization 
Efficacy. J. Phys. Chem. B 2017, 121, 8756–8766, doi:10.1021/acs.jpcb.7b03989. 
115. Matsuoka, K.; Takahashi, N.; Yada, S.; Yoshimura, T. Solubilization ability of star-shaped trimeric 
quaternary ammonium bromide surfactant. J. Mol. Liq. 2019, 291, 111254, 
doi:https://doi.org/10.1016/j.molliq.2019.111254. 
116. Choudhary, S.; Talele, P.; Kishore, N. Thermodynamic insights into drug–surfactant interactions: Study of 
the interactions of naporxen, diclofenac sodium, neomycin, and lincomycin with 
hexadecytrimethylammonium bromide by using isothermal titration calorimetry. Colloids Surf. B 2015, 132, 
313–321, doi:https://doi.org/10.1016/j.colsurfb.2015.05.031. 
117. Hoque, M.A.; Hossain, M.D.; Khan, M.A. Interaction of cephalosporin drugs with 
dodecyltrimethylammonium bromide. J. Chem. Thermodyn. 2013, 63, 135–141. 
118. Grujić, M.; Popović, M.; Popović, G.; Nikolic, K.; Agbaba, D. Protolytic Equilibria of Sartans in Micellar 
Solutions of Differently Charged Surfactants. J. Pharm. Sci. 2016, 105, 2444–2452, 
doi:10.1016/j.xphs.2016.06.007. 
119. Sanan, R.; Kaur, R.; Mahajan, R.K. Micellar transitions in catanionic ionic liquid–ibuprofen aqueous 
mixtures; effects of composition and dilution. Rsc Adv. 2014, 4, 64877–64889. 
120. Lin, Y.A.; Cheetham, A.G.; Zhang, P.; Ou, Y.C.; Li, Y.; Liu, G.; Hermida-Merino, D.; Hamley, I.W.; Cui, H. 
Multiwalled nanotubes formed by catanionic mixtures of drug amphiphiles. Acs Nano 2014, 8, 12690–12700, 
doi:10.1021/nn505688b. 
121. Nnyigide, O.S.; Lee, S.-G.; Hyun, K. In Silico Characterization of the Binding Modes of Surfactants with 
Bovine Serum Albumin. Sci. Rep. 2019, 9, 10643, doi:10.1038/s41598-019-47135-2. 
122. Wang, Y.; Jiang, X.; Zhou, L.; Yang, L.; Xia, G.; Chen, Z.; Duan, M. Synthesis and binding with BSA of a 
new gemini surfactant. Colloids Surf. A 2013, 436, 1159–1169, 
doi:http://dx.doi.org/10.1016/j.colsurfa.2013.08.045. 
123. Choudhary, S.; Kishore, N. Drug-protein interactions in micellar media: Thermodynamic aspects. J. Colloid 
Interface Sci. 2014, 413, 118–126, doi:10.1016/j.jcis.2013.09.026S0021-9797(13)00855-2 [pii]. 
124. Takayama, K.; Hirose, H.; Tanaka, G.; Pujals, S.; Katayama, S.; Nakase, I.; Futaki, S. Effect of the attachment 
of a penetration accelerating sequence and the influence of hydrophobicity on octaarginine-mediated 
intracellular delivery. Mol. Pharm. 2012, 9, 1222–1230, doi:10.1021/mp200518n. 
125. Ye, G.; Nam, N.H.; Kumar, A.; Saleh, A.; Shenoy, D.B.; Amiji, M.M.; Lin, X.; Sun, G.; Parang, K. Synthesis 
and evaluation of tripodal peptide analogues for cellular delivery of phosphopeptides. J. Med. Chem. 2007, 
50, 3604–3617, doi:10.1021/jm070416o. 
126. Cheetham, A.G.; Zhang, P.; Lin, Y.A.; Lock, L.L.; Cui, H. Supramolecular nanostructures formed by 
anticancer drug assembly. J. Am. Chem. Soc. 2013, 135, 2907–2910, doi:10.1021/ja3115983. 
127. Lin, R.; Zhang, P.; Cheetham, A.G.; Walston, J.; Abadir, P.; Cui, H. Dual peptide conjugation strategy for 
improved cellular uptake and mitochondria targeting. Bioconjug. Chem. 2015, 26, 71–77, 
doi:10.1021/bc500408p. 
128. Severino, P.; Szymanski, M.; Favaro, M.; Azzoni, A.R.; Chaud, M.V.; Santana, M.H.; Silva, A.M.; Souto, E.B. 
Development and characterization of a cationic lipid nanocarrier as non-viral vector for gene therapy. Eur. 
J. Pharm. Sci. 2015, 66, 78–82, doi:10.1016/j.ejps.2014.09.021. 
129. Andrzejewska, W.; Wilkowska, M.; Chrabąszczewska, M.; Kozak, M. The study of complexation between 
dicationic surfactants and the DNA duplex using structural and spectroscopic methods. Rsc Adv. 2017, 7, 
26006–26018, doi:10.1039/C6RA24978G. 
130. Cardoso, A.M.; Morais, C.M.; Silva, S.G.; Marques, E.F.; de Lima, M.C.; Jurado, M.A. Bis-quaternary gemini 
surfactants as components of nonviral gene delivery systems: A comprehensive study from 
Int. J. Mol. Sci. 2019, 20, 5534 30 of 32 
physicochemical properties to membrane interactions. Int. J. Pharm. 2014, 474, 57–69, 
doi:10.1016/j.ijpharm.2014.08.011. 
131. Zakharova, L.; Voronin, M.; Semenov, V.; Gabdrakhmanov, D.; Syakaev, V.; Gogolev, Y.; Giniyatullin, R.; 
Lukashenko, S.; Reznik, V.; Latypov, S., et al. Supramolecular Systems Based on Novel Mono- and 
Dicationic Pyrimidinic Amphiphiles and Oligonucleotides: A Self-Organization and Complexation Study. 
Chem. Phys. Chem. 2012, 13, 788–796, doi:10.1002/cphc.201100888. 
132. Zakharova, L.Y.; Kashapov, R.R.; Vagapova, G.I.; Gabdrakhmanov, D.R.; Vasilieva, E.A. Comparative 
Study of Aqueous Solutions of Cationic Surfactants: Structure/Activity Relation in Their Aggregation and 
Solubilization Behavior and Complexation with an Oligonucleotide. Chem. Lett. 2012, 41, 1226–1228, 
doi:10.1246/cl.2012.1226. 
133. Sharma, V.D.; Lees, J.; Hoffman, N.E.; Brailoiu, E.; Madesh, M.; Wunder, S.L.; Ilies, M.A. Modulation of 
pyridinium cationic lipid-DNA complex properties by pyridinium gemini surfactants and its impact on 
lipoplex transfection properties. Mol. Pharm. 2014, 11, 545–559, doi:10.1021/mp4005035. 
134. Zakharova, L.Y.; Gabdrakhmanov, D.R.; Ibragimova, A.R.; Vasilieva, E.A.; Nizameev, I.R.; Kadirov, M.K.; 
Ermakova, E.A.; Gogoleva, N.E.; Faizullin, D.A.; Pokrovsky, A.G., et al. Structural, biocomplexation and 
gene delivery properties of hydroxyethylated gemini surfactants with varied spacer length. Colloids Surf. B 
2016, 140, 269–277, doi:https://doi.org/10.1016/j.colsurfb.2015.12.045. 
135. Lukac, M.; Mojzis, J.; Mojzisova, G.; Mrva, M.; Ondriska, F.; Valentova, J.; Lacko, I.; Bukovsky, M.; 
Devinsky, F.; Karlovska, J. Dialkylamino and nitrogen heterocyclic analogues of hexadecylphosphocholine 
and cetyltrimetylammonium bromide: Effect of phosphate group and environment of the ammonium 
cation on their biological activity. Eur. J. Med. Chem. 2009, 44, 4970–4977, doi:10.1016/j.ejmech.2009.08.011. 
136. Sauerová, P.; Pilgrová, T.; Pekař, M.; Hubálek Kalbáčová, M. Hyaluronic acid in complexes with 
surfactants: The efficient tool for reduction of the cytotoxic effect of surfactants on human cell types. Int. J. 
Biol. Macromol. 2017, 103, 1276–1284, doi:https://doi.org/10.1016/j.ijbiomac.2017.05.173. 
137. Zupancic, S.; Kocbek, P.; Zariwala, M.G.; Renshaw, D.; Gul, M.O.; Elsaid, Z.; Taylor, K.M.; Somavarapu, S. 
Design and development of novel mitochondrial targeted nanocarriers, DQAsomes for curcumin 
inhalation. Mol. Pharm. 2014, 11, 2334–2345, doi:10.1021/mp500003q. 
138. Pashirova, T.N.; Ziganshina, А.Y.; Sultanova, E.D.; Lukashenko, S.S.; Kudryashova, Y.R.; Zhiltsova, E.P.; 
Zakharova, L.Y.; Konovalov, A.I. Supramolecular systems based on calix[4]resorcine with mono-, di-, and 
tetracationic surfactants: Synergetic structural and solubilization behavior. Colloids Surf. A 2014, 448, 67–72, 
doi:10.1016/j.colsurfa.2014.02.012. 
139. Engel, R.; Ghani, I.; Montenegro, D.; Thomas, M.; Klaritch-Vrana, B.; Castano, A.; Friedman, L.; Leb, J.; 
Rothman, L.; Lee, H., et al. Polycationic glycosides. Molecules 2011, 16, 1508–1518, 
doi:10.3390/molecules16021508molecules16021508 [pii]. 
140. Burakova, E.; Kovalev, N.; Zenkova, M.; Vlassov, V.; Silnikov, V. Structure–activity relationships in new 
polycationic molecules based on two 1,4-diazabicyclo[2.2.2]octanes as artificial ribonucleases. Bioorganic 
Chem. 2014, 57, 127–131, doi:10.1016/j.bioorg.2014.10.002. 
141. Zhiltsova, E.P.; Lukashenko, S.S.; Pashirova, T.N.; Valeeva, F.G.; Zakharova, L.Y. Self-assembling systems 
based on diquaternized derivatives of 1,4-diazabicyclo[2.2.2]octane. J. Mol. Liq. 2015, 
doi:10.1016/j.molliq.2015.01.018. 
142. Pashirova, T.N.; Lukashenko, S.S.; Zakharov, S.V.; Voloshina, A.D.; Zhiltsova, E.P.; Zobov, V.V.; Souto, 
E.B.; Zakharova, L.Y. Self-assembling systems based on quaternized derivatives of 1,4-
diazabicyclo[2.2.2]octane in nutrient broth as antimicrobial agents and carriers for hydrophobic drugs. 
Colloids Surf. B 2015, 127, 266–273, doi:10.1016/j.colsurfb.2015.01.044. 
143. Burilova, E.A.; Pashirova, T.N.; Lukashenko, S.S.; Sapunova, A.S.; Voloshina, A.D.; Zhiltsova, E.P.; 
Campos, J.R.; Souto, E.B.; Zakharova, L.Y. Synthesis, biological evaluation and structure-activity 
relationships of self-assembled and solubilization properties of amphiphilic quaternary ammonium 
derivatives of quinuclidine. J. Mol. Liq. 2018, 272, 722–730, doi:https://doi.org/10.1016/j.molliq.2018.10.008. 
144. Pashirova, T.N.; Zhil’tsova, E.P.; Kashapov, R.R.; Lukashenko, S.S.; Litvinov, A.I.; Kadirov, M.K.; 
Zakharova, L.Y.; Konovalov, A.I. Supramolecular systems based on 1-alkyl-4-aza-1-
azoniabicyclo[2.2.2]octane bromides. Russ. Chem. Bull. 2010, 1745—1175. 
145. Kashapov, R.R.; Pashirova, T.N.; Kharlamov, S.V.; Ziganshina, A.Y.; Ziltsova, E.P.; Lukashenko, S.S.; 
Zakharova, L.Y.; Habicher, W.D.; Latypov, S.K.; Konovalov, A.I. Novel self-assembling system based on 
Int. J. Mol. Sci. 2019, 20, 5534 31 of 32 
resorcinarene and cationic surfactant. Phys. Chem. Chem. Phys. 2011, 13, 15891–15898, 
doi:10.1039/c1cp20906j. 
146. Kharlamov, S.V.; Kashapov, R.R.; Pashirova, T.N.; Zhiltsova, E.P.; Lukashenko, S.S.; Ziganshina, A.Y.; 
Gubaidullin, A.T.; Zakharova, L.Y.; Gruner, M.; Habicher, W.D., et al. A Supramolecular Amphiphile Based 
on Calix[4]resorcinarene and Cationic Surfactant for Controlled Self-Assembly. J. Phys. Chem. C 2013, 117, 
20280–20288, doi:10.1021/jp406643g. 
147. Kashapov, R.R.; Pashirova, T.N.; Zhiltsova, E.P.; Lukashenko, S.S.; Ziganshina, A.Y.; Zakharova, L.Y. 
Supramolecular systems based on aminomethylated calix[4]resorcinarene and a cationic surfactant: 
Catalysts of the hydrolysis of esters of phosphorus acids. Russ. J. Phys. Chem. A 2012, 86, 200–204, 
doi:10.1134/s003602441201013x. 
148. Zhiltsova, E.P.; Pashirova, T.N.; Kashapov, R.R.; Gaisin, N.K.; Gnezdilov, O.I.; Lukashenko, S.S.; Voloshina, 
A.D.; Kulik, N.V.; Zobov, V.V.; Zakharova, L.Y., et al. Alkylated 1,4- diazabicyclo[2.2.2]octanes: Self-
association, catalytic properties, and biological activity. Russ. Chem. Bull. 2012, 61, 113–120. 
149. Zakharova, L.Y.; Pashirova, T.N.; Kashapov, R.R.; Zhil’tsova, E.P.; Gaisin, N.K.; Gnezdilov, O.I.; Konov, 
A.B.; Lukashenko, S.S.; Magdeev, I.M. Catalytic properties of micellar systems based on 4-aza-1-alkyl-1-
azoniabicyclo[2.2.2]octane bromides. Kinet. Catal. 2011, 52, 179–185, doi:10.1134/s0023158411020236. 
150. Zhil’tsova, E.P.; Gimranova, R.F.; Lukashenko, S.S.; Pashirova, T.N.; Kharlampidi, K.E.; Zakharova, L.Y. 
Supramolecular catalytic systems based on alkylated diquaternary 1,4-diazabicyclo[2.2.2]octane 
derivatives. Kinet. Catal. 2013, 54, 552–558, doi:10.1134/s0023158413050200. 
151. Zhil’tsova, E.P.; Kashapov, R.R.; Zakharova, L.Y.; Lukashenko, S.S.; Timosheva, A.P.; Kasymova, E.M.; 
Kayupov, A.R.; Burilov, A.R. Alkylated polyethyleneimine-cationic surfactant-calix[4]resorcinarene-
chloroform catalytic system. Kinet. Catal. 2012, 53, 231–238, doi:10.1134/s0023158412020176. 
152. Valeeva, F.G.; Kuryashov, D.A.; Zakharov, S.V.; Vagapova, G.I.; Vasilieva, E.A.; Bashkirtseva, N.Y.; 
Zakharova, L.Y.; Konovalov, A.I. Supramolecular system 4-aza-1-hexadecyl-1-azoniabicyclo[2.2.2]octane 
bromide-sodium salicylate. Russ. Chem. Bull. 2013, 62, 989–993. 
153. Gaisin, N.K.; Gnezdilov, O.I.; Pashirova, T.N.; Zhil’tsova, E.P.; Lukashenko, S.S.; Zakharova, L.Y.; Osipova, 
V.V.; Dzhabarov, V.I.; Galyametdinov, Y.G. Micellar and liquid-crystalline properties of bicyclic fragment-
containing cationic surfactant. Colloid J. 2010, 72, 764–770, doi:10.1134/s1061933x10060062. 
154. Zakharova, L.Y.; Gaysin, N.K.; Gnezdilov, O.I.; Bashirov, F.I.; Kashapov, R.R.; Zhiltsova, E.P.; Pashirova, 
T.N.; Lukashenko, S.S. Micellization of alkylated 1.4-diazabicyclo[2.2.2]octane by nuclear magnetic 
resonance technique using pulsed gradient of static magnetic field. J. Mol. Liq. 2012, 167, 89–93, 
doi:10.1016/j.molliq.2011.12.015. 
155. Gaynanova, G.A.; Vagapova, G.I.; Valeeva, F.G.; Vasilieva, E.A.; Galkina, I.V.; Zakharova, L.Y.; Sinyashin, 
O.G. A novel supramolecular catalytic system based on amphiphilic triphenylphosphonium bromide for 
the hydrolysis of phosphorus acid esters. Colloids Surf. A 2016, 489, 95–102, 
doi:https://doi.org/10.1016/j.colsurfa.2015.10.032. 
156. Pashirova, T.; Burilova, E.; Lukashenko, S.; Gaysin, N.; Gnezdilov, O.; Sapunova, A.; Fernandes, A.; 
Voloshina, A.; Souto, E.B.; Zhiltsova, E.; et al. Nontoxic antimicrobial micellar systems based on mono- and 
di-cationic Dabco-surfactants and furazolidone: Structure-solubilization properties relationships. J. Mol. 
Liq. 2019, accepted. 
157. Zhiltsova, E.P. Lukashenko S.S, Pashirova T.N., Zakharova L.Ya., Konovalov A.I. Supramolecular catalytic 
systems based on 1,4-vdiazabicyclo[2.2.2]octane, its alkylated quaternary derivatives and lanthanum 
nitrate. Russ. Chem. Bull., Int. Ed. 2015, 64, 2690–2696. 
158. Pashirova, T.N., Zhiltsova E.P., Lukashenko S.S., Gabdrakhmanov D.R., Zakharova L.Ya., Konovalov A.I. 
Mono-, bis- and tetra-quaternary derivatives of 1,4-diazabicyclo[2.2.2]octane: Self-assemble behavior and 
properties. In Proceedings of SIS, Coimbra, Portugal; p. 266, 
http://www.uc.pt/fctuc/dquimica/sis2014/programme/Poster1 (access on 6 November 2019). 
159. Sun, T.; Shen, J.; Yan, H.; Hao, J.; Hao, A. Stable vesicles assembled by “supramolecular amphiphiles” with 
double hydrophobic chains. Colloids Surf. A 2012, 414, 41–49, doi:10.1016/j.colsurfa.2012.08.045. 
160. Zhang, X.; Wang, C. Supramolecular amphiphiles. Chem Soc. Rev. 2011, 40, 94–101, doi:10.1039/b919678c. 
161. Li, J.; Jiang, H.; Hu, W.; Zou, G.; Zhang, Q. Morphology modulation in an azobenzene based 
supramolecular amphiphiles system. J. Photochem. Photobiol. A. 2012, 245, 28–32, 
doi:10.1016/j.jphotochem.2012.07.003. 
Int. J. Mol. Sci. 2019, 20, 5534 32 of 32 
162. Wang, K.; Guo, D.S.; Liu, Y. Temperature-controlled supramolecular vesicles modulated by p-
sulfonatocalix[5]arene with pyrene. Chemistry 2010, 16, 8006–8011, doi:10.1002/chem.201000991. 
163. Mura, S.; Nicolas, J.; Couvreur, P. Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 2013, 12, 
991–1003, doi:10.1038/nmat3776nmat3776 [pii]. 
164. Uhlenheuer, D.A.; Petkau, K.; Brunsveld, L. Combining supramolecular chemistry with biology. Chem. Soc. 
Rev. 2010, 39, 2817–2826, doi:10.1039/b820283b. 
165. Wang, J.; Ding, X.; Guo, X. Assembly behaviors of calixarene-based amphiphile and supra-amphiphile and 
the applications in drug delivery and protein recognition. Adv. Colloid Interface Sci. 2019, 269, 187–202, 
doi:https://doi.org/10.1016/j.cis.2019.04.004. 
166. Pashirova, T.N.; Gibadullina, E.M.; Burilov, A.R.; Kashapov, R.R.; Zhiltsova, E.P.; Syakaev, V.V.; Habicher, 
W.D.; Rummeli, M.H.; Latypov, S.K.; Konovalov, A.I.; et al. Amphiphilic O-functionalized 
calix[4]resocinarenes with tunable structural behavior. Rsc Adv. 2014, 4, 9912–9919, doi:10.1039/c3ra46146g. 
167. Kashapov, R.R.; Kharlamov, S.V.; Sultanova, E.D.; Mukhitova, R.K.; Kudryashova, Y.R.; Zakharova, L.Y.; 
Ziganshina, A.Y.; Konovalov, A.I. Controlling the size and morphology of supramolecular assemblies of 
viologen-resorcin[4]arene cavitands. Chemistry 2014, 20, 14018–14025, doi:10.1002/chem.201403721. 
168. Lehn, J.-M. Supramolecular Reactivity and Catalysis. In Supramolecular Chemistry, Wiley-VCH Verlag 
GmbH & Co. KGaA: Weinheim, Germany. 2006; pp. 55-67. doi:10.1002/3527607439.ch5 
169. Rico-Lattes, I.; Perez, E.; Franceschi-Messant, S.; Lattes, A. Organized molecular systems as reaction media. 
Comptes Rendus Chim. 2011, 14, 700–715, doi:10.1016/j.crci.2011.01.005. 
170. Gilbert, P.; Al-taae, A. Antimicrobial activity of some alkyltrimethylammonium bromides. Lett. Appl. 
Microbiol. 1985, 1, 101–104, doi:10.1111/j.1472-765X.1985.tb01498.x. 
171. Daoud, N.N.D.; Dickinson, N.A.; Gilbert, P. Antibacterial activity and physico-chemical properties of some 
alkyl-dimethylbenzyl ammonium chlorides. Microbios 1983, 37, 75–85. 
 
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access 
article distributed under the terms and conditions of the Creative Commons Attribution 
(CC BY) license (http://creativecommons.org/licenses/by/4.0/). 
 
 
